TW201427703A - Emulsion cosmetic composition - Google Patents

Emulsion cosmetic composition Download PDF

Info

Publication number
TW201427703A
TW201427703A TW102144187A TW102144187A TW201427703A TW 201427703 A TW201427703 A TW 201427703A TW 102144187 A TW102144187 A TW 102144187A TW 102144187 A TW102144187 A TW 102144187A TW 201427703 A TW201427703 A TW 201427703A
Authority
TW
Taiwan
Prior art keywords
group
component
mass
hydrogen atom
emulsified cosmetic
Prior art date
Application number
TW102144187A
Other languages
Chinese (zh)
Inventor
Chihiro Ueyama
Hidehiro Nagasawa
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of TW201427703A publication Critical patent/TW201427703A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/025Explicitly spheroidal or spherical shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0279Porous; Hollow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

An emulsion cosmetic composition which contains (A) 0.01-10% by mass of one or more compounds that are selected from among sphingosine salts and ionic surfactants, (B) one or more compounds that are selected from among linear glycerol di-fatty acid esters and linear sorbitan di-fatty acid esters, (C) an alcohol having 12-22 carbon atoms, a glycerol mono-fatty acid ester having 12-22 carbon atoms, or the like, (D) 0.01-30% by mass of a powder having an average particle diameter of 0.1-30 [mu]m and (E) water. With respect to the components (A), (B) and (C), (1) the mass ratio of (A)/((B) + (C)) is 0.04-1, (2) the molar fraction of (B)/((B) + (C)) is 0.01-0.45, and (3) the maximum molar fraction of a single compound component in the components (B) and (C) is 0.2-0.8.

Description

乳化化妝料 Emulsifying cosmetic

本發明係關於乳化化妝料。 The present invention relates to emulsified cosmetic materials.

α-凝膠係水和型之結晶構造,具有片層狀(lamellar)構造。存在於皮膚最外層之角質層的角質層細胞間質,其大半亦形成此種α-凝膠構造,對於皮膚,抑制來自外部的物質侵入、從內部的水分蒸散,同時其本身保持水份,故具有保持皮膚之柔軟性或滑順外觀的功能。因此,作為為了得到保濕效果之化妝料等,已檢討有形成液晶構造的組成物,但形成α-凝膠的組成物存在有於塗佈至皮膚後,因經時而產生黏瘩的問題。 The α-gel water and the crystal structure of the type have a lamellar structure. The stratum corneum interstitial cells present in the stratum corneum of the outermost layer of the skin also form such an α-gel structure. For the skin, the intrusion of substances from the outside is suppressed, and the water is evaporated from the inside while maintaining moisture itself. Therefore, it has the function of keeping the skin soft or smooth. Therefore, as a cosmetic material or the like for obtaining a moisturizing effect, a composition for forming a liquid crystal structure has been examined. However, the composition forming the α-gel has a problem of sticking with time after application to the skin.

因此,檢討有於α-凝膠調配粉體,以得到清爽感(專利文獻1)。 Therefore, it is reviewed that the powder is formulated in the α-gel to obtain a refreshing feeling (Patent Document 1).

另外,於專利文獻2記載有一種使用HLB10以下之界面活性劑而形成片層狀液晶構造,並調配了粉體的化妝料。 Further, Patent Document 2 discloses a cosmetic which is formed by using a surfactant having an HLB of 10 or less to form a lamellar liquid crystal structure and blending a powder.

[專利文獻] [Patent Literature]

[專利文獻1]日本專利特開2006-36763號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. 2006-36763

[專利文獻2]日本專利特開2006-56851號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2006-56851

本發明係關於一種乳化化妝料,其含有下述成分(A)、 (B)、(C)、(D)及(E):(A)由神經胺醇鹽及離子性界面活性劑所選擇之1種或2種以上的化合物0.01~10質量%;(B)由二直鏈脂肪酸甘油酯及二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物;(C)由一般式(3)所示之化合物、碳數12~22之醇、碳數12~22之單脂肪酸甘油酯、碳數12~22之單烷基甘油醚及碳數12~22之單脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物; The present invention relates to an emulsified cosmetic comprising the following components (A), (B), (C), (D) and (E): (A) selected from a neuroamine alkoxide and an ionic surfactant (1) one or two or more compounds selected from the group consisting of a di-linear fatty acid glyceride and a di-linear fatty acid sorbitan ester; (C) a compound represented by the general formula (3), an alcohol having 12 to 22 carbon atoms, a monoglyceride having 12 to 22 carbon atoms, a monoalkyl glyceryl ether having 12 to 22 carbon atoms, and a single fatty acid having 12 to 22 carbon atoms One or more compounds selected from sorbitan esters;

(式中,R11表示亦可取代有羥基、羰基或胺基的碳數4~30之直鏈、分枝鏈或環狀之飽和或不飽和的烴基或氫原子;Z表示亞甲基、次甲基或氧原子;X11、X12及X13分別獨立表示氫原子、羥基或乙醯氧基;X14表示氫原子、乙醯基或甘油基,或與相鄰接之氧原子一起形成側氧基(但,在Z為次甲基時,X11與X12之任一者為氫原子、另一者不存在;在X14形成側氧基時,X13不存在);R12及R13分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;R14表示亦可取代有羥基、羰基或胺基之於主鏈亦可具有醚鍵、酯鍵或醯胺鍵的碳數5~60之直鏈、分枝鏈或環狀之飽和或不飽和的烴基;R15表示氫原子,或亦可具有由羥基、 羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~30之直鏈或分枝鏈的飽和或不飽和的烴基(但,在R11為氫原子、Z為氧原子時,R15為總碳數10~30之烴基;在R11為烴基時,R15為總碳數1~8之烴基);虛線部表示亦可為不飽和鍵);(D)平均粒徑0.1~30μm之粉體0.01~30質量%;(E)水;成分(A)、(B)及(C)中,(1)(A)/((B)+(C))之質量比為0.04~1;(2)(B)/((B)+(C))之莫耳分率為0.01~0.45;(3)(B)+(C)構成成分中之1化合物單成分所佔有之最大莫耳分率為0.2~0.8。 (wherein R 11 represents a straight-chain, branched chain or cyclic saturated or unsaturated hydrocarbon group or hydrogen atom which may have a hydroxyl group, a carbonyl group or an amine group of 4 to 30; Z represents a methylene group, a methine or an oxygen atom; X 11 , X 12 and X 13 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 14 represents a hydrogen atom, an ethyl fluorenyl group or a glyceryl group, or together with an adjacent oxygen atom Forming a pendant oxy group (however, when Z is a methine group, either of X 11 and X 12 is a hydrogen atom, the other is absent; when X 14 forms a pendant oxy group, X 13 is absent); 12 and R 13 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; and R 14 represents a hydroxyl group, a carbonyl group or an amine group which may be substituted with a hydroxyl group, an ester bond or an anthracene. A linear, branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 5 to 60; R 15 represents a hydrogen atom, or may have a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an acetamidine group; a saturated or unsaturated hydrocarbon group of a linear or branched chain having a total carbon number of 1 to 30, which is a substituent selected from the oxy group (however, when R 11 is a hydrogen atom and Z is an oxygen atom, R 15 is a total carbon number) 10~3 a hydrocarbon group of 0; when R 11 is a hydrocarbon group, R 15 is a hydrocarbon group having a total carbon number of 1 to 8); a broken line portion may also be an unsaturated bond; (D) a powder having an average particle diameter of 0.1 to 30 μm 0.01 to 30 Mass %; (E) water; in the components (A), (B) and (C), the mass ratio of (1) (A) / ((B) + (C)) is 0.04 ~ 1; (2) ( B) / ((B) + (C)) has a molar fraction of 0.01 to 0.45; (3) (B) + (C) The composition of the compound has a maximum molar fraction of 0.2. ~0.8.

專利文獻1記載之組成物,於塗佈時液晶構造崩壞,不形成α-凝膠被膜,故難以使粉體均勻附著,亦難以兼顧高保濕效果與持續無黏瘩。又,專利文獻2記載之組成物對於片層狀液晶構造與粉體之相關性的具體效果並無記載。 In the composition described in Patent Document 1, the liquid crystal structure collapses during coating, and the α-gel film is not formed. Therefore, it is difficult to uniformly adhere the powder, and it is difficult to achieve both a high moisturizing effect and no stickiness. Further, the composition described in Patent Document 2 does not describe the specific effects of the correlation between the lamellar liquid crystal structure and the powder.

本發明係關於在塗佈至皮膚時,於皮膚表面形成含有粉體、均勻且柔軟之片層狀之α-凝膠構造的皮膜,粉體均勻附著而即使施加摩擦亦不易脫離,持續著高保濕效果與無黏瘩的乳化化妝料。 The present invention relates to a film comprising an α-gel structure containing a powder, a uniform and soft layer on the surface of the skin when applied to the skin, the powder is uniformly attached and is not easily detached even if friction is applied, and continues to be high. Moisturizing effect and non-sticky emulsified cosmetic.

本發明者等人發現,藉由將(A)由神經胺醇鹽及離子性界面活性劑所選擇之1種或2種以上的化合物、(B)由二直鏈脂肪酸甘油酯及二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物、 (C)由腦醯胺、高級醇、單甘油單脂肪酸酯、單烷基甘油醚、去水山梨醇單脂肪酸酯所選擇之1種或2種以上的化合物、(D)粉體調整為特定範圍內,可於皮膚表面形成含有粉體、均勻且柔軟之片層狀α-凝膠構造的皮膜,粉體均勻附著而即使施加摩擦亦不易脫離,持續著高保濕效果與無黏瘩。 The present inventors have found that (A) one or two or more compounds selected from a neuroamine alkoxide and an ionic surfactant, (B) a di-linear fatty acid glyceride, and a two-linear chain One or more compounds selected from fatty acid sorbitan esters, (C) One or two or more compounds selected from ceramide, higher alcohol, monoglycerin mono-fatty acid ester, monoalkyl glyceryl ether, and sorbitan mono-fatty acid ester, and (D) powder adjustment In a specific range, a film containing a powder, a uniform and soft lamellar α-gel structure can be formed on the surface of the skin, and the powder adheres evenly and is not easily detached even if friction is applied, and the high moisturizing effect and the non-adhesiveness are continued. .

本發明之乳化化妝料係於塗佈後,於皮膚表面形成含有粉體、均勻且柔軟之片層狀α-凝膠構造的皮膜,粉體均勻附著而即使施加摩擦亦不易脫離,持續著高保濕效果與無黏瘩。 The emulsified cosmetic of the present invention forms a film containing a powder and a uniform and soft lamellar α-gel structure on the surface of the skin after application, and the powder adheres uniformly and is not easily detached even if friction is applied, and continues to be high. Moisturizing effect and no stickiness.

[成分A] [ingredient A]

本發明所使用之成分(A)係由神經胺醇鹽及離子性界面活性劑所選擇之1種或2種以上的化合物。又,於此,所謂2種以上之化合物,係例如即使是分類為相同離子性界面活性劑的化合物,若構造相異,則仍視為2種以上。 The component (A) used in the present invention is one or two or more compounds selected from the group consisting of a neuroamine alkoxide and an ionic surfactant. In addition, the compound of two or more types is, for example, a compound classified into the same ionic surfactant, and two or more types are considered to have different structures.

本發明所使用之成分(A)之化合物中,作為神經胺醇,可列舉一般式(1)所示之神經胺醇。 In the compound of the component (A) used in the present invention, examples of the neuroamine alcohol include a neuroamine alcohol represented by the general formula (1).

(式中,R1表示亦可取代有羥基、羰基或胺基之碳數4~30之直鏈、分枝鏈或環狀的飽和或不飽和的烴基;Y表示亞甲基、次甲基或氧原子;X1、X2及X3分別獨立表示氫原子、羥基或乙醯氧基; X4表示氫原子、乙醯基或甘油基,或者與相鄰接之氧原子一起形成側氧基(但,在Y為次甲基時,X1與X2之任一者為氫原子、另一者不存在;在X4形成側氧基時,X3不存在);R2及R3分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;a個之R分別獨立為氫原子或甲脒基,或者表示亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~8之直鏈或分枝鏈的飽和或不飽和的烴基;a表示2或3之數;虛線部表示亦可為不飽和鍵)。 (wherein R 1 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group which may have a carbon number, a carbonyl group or an amine group of 4 to 30 carbon atoms; Y represents a methylene group and a methine group; Or an oxygen atom; X 1 , X 2 and X 3 each independently represent a hydrogen atom, a hydroxyl group or an ethyloxy group; X 4 represents a hydrogen atom, an ethenyl group or a glyceryl group, or forms a side oxygen together with an adjacent oxygen atom; a group (however, when Y is a methine group, either of X 1 and X 2 is a hydrogen atom, the other is absent; when X 4 forms a pendant oxy group, X 3 is absent); R 2 and R 3 independently represents a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; each of R is independently a hydrogen atom or a formazan group, or may have a hydroxyl group, a hydroxyalkoxy group or an alkoxy group. And a saturated or unsaturated hydrocarbon group of a linear or branched chain having a total carbon number of 1 to 8 and a substituent selected from an ethoxy group; a represents a number of 2 or 3; and a dotted line indicates an unsaturated bond) .

式中,R1表示亦可取代有羥基、羰基或胺基之碳數4~30、較佳係亦可取代有羥基之碳數7~22之直鏈、分枝鏈或環狀的飽和或不飽和的烴基。特佳係碳數10~20之直鏈或分枝鏈之烷基、於Y側末端具有羥基之碳數10~20之直鏈或分枝鏈之烷基,在分枝鏈烷基的情況為甲基分枝物等。具體而言,較佳為十三基、十四基、十五基、十六基、1-羥基十三基、1-羥基十五基、異十六基、異硬脂基。 In the formula, R 1 represents a linear, branched or cyclic saturated or substituted carbon group having a hydroxyl group, a carbonyl group or an amine group of 4 to 30, preferably substituted with a hydroxyl group having 7 to 22 carbon atoms; Unsaturated hydrocarbon group. Particularly preferred is a linear or branched alkyl group having a carbon number of 10 to 20, and a linear or branched alkyl group having a hydroxyl group of 10 to 20 at the terminal of the Y side, in the case of a branched alkyl group. It is a methyl branch or the like. Specifically, it is preferably a thirteen group, a tetradecyl group, a fifteen group, a hexadecyl group, a 1-hydroxytridecyl group, a 1-hydroxypentadecyl group, an isohexadecyl group or an isostearyl group.

Y表示亞甲基(CH2)、次甲基(CH)或氧原子。 Y represents a methylene group (CH 2 ), a methine group (CH) or an oxygen atom.

X1、X2及X3分別獨立表示氫原子、羥基或乙醯氧基;X4表示氫原子、乙醯基或甘油基,或者與相鄰接之氧原子一起形成側氧基之取代基。特佳係X1、X2及X3中0~1個為羥基、剩餘為氫原子、及X4為氫原子者。又,在Y為次甲基時,X1與X2之任一者為氫原子、另一者不存在。又,在X4形成側氧基時,X3不存在。 X 1 , X 2 and X 3 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 4 represents a hydrogen atom, an ethenyl group or a glyceryl group, or a substituent which forms a pendant oxy group together with an adjacent oxygen atom; . Particularly preferably, 0 to 1 of X 1 , X 2 and X 3 are a hydroxyl group, the remainder is a hydrogen atom, and X 4 is a hydrogen atom. Further, when Y is a methine group, either of X 1 and X 2 is a hydrogen atom, and the other is not present. Further, when X 4 forms a pendant oxy group, X 3 does not exist.

R2及R3分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;特佳係R3為氫原子。 R 2 and R 3 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; and particularly preferably R 3 is a hydrogen atom.

又,a表示2或3之數,在a為2時R表示R4及R5,在a為3時R表示R4、R5及R6Further, a represents a number of 2 or 3, and when a is 2, R represents R 4 and R 5 , and when a is 3, R represents R 4 , R 5 and R 6 .

R4、R5及R6分別獨立為氫原子或甲脒基,或者表示亦 可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~8之直鏈或分枝鏈的飽和或不飽和的烴基。於此,作為可於烴基上取代之羥基烷氧基,較佳為碳數1~7之直鏈或分枝鏈的羥基烷氧基。又,作為烷氧基,較佳為碳數1~7之直鏈或分枝鏈之烷氧基。作為R4、R5及R6,可列舉例如氫原子;甲基、乙基、丙基、2-乙基己基、異丙基等之直鏈或分枝鏈烷基;乙烯基、烯丙基等之烯基;甲脒基;由羥基甲基、2-羥基乙基、1,1-二甲基-2-羥基乙基、2-羥基丙基、2,3-二羥基丙基、2-羥基-3-甲氧基丙基、2,3,4,5,6-五羥基己基、1,1-雙(羥基甲基)乙基、2-(2-羥基乙氧基)乙基、2-甲氧基乙基、1-甲基-2-羥基乙基、3-羥基丙基、3-甲氧基丙基、1,1-雙(羥基甲基)-2-羥基乙基等之羥基、羥基烷氧基及烷氧基所選擇之經1~6個取代的總碳數1~8之烴基。 R 4 , R 5 and R 6 are each independently a hydrogen atom or a fluorenyl group, or a total carbon number of a substituent which may also have a substituent selected from a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethoxy group. A saturated or unsaturated hydrocarbon group of a straight or branched chain of 8. Here, as the hydroxyalkoxy group which may be substituted on the hydrocarbon group, a linear or branched hydroxyalkoxy group having 1 to 7 carbon atoms is preferable. Further, the alkoxy group is preferably a linear or branched alkoxy group having 1 to 7 carbon atoms. Examples of R 4 , R 5 and R 6 include a hydrogen atom; a linear or branched alkyl group such as a methyl group, an ethyl group, a propyl group, a 2-ethylhexyl group or an isopropyl group; and a vinyl group; Alkenyl group; methyl group; by hydroxymethyl, 2-hydroxyethyl, 1,1-dimethyl-2-hydroxyethyl, 2-hydroxypropyl, 2,3-dihydroxypropyl, 2-hydroxy-3-methoxypropyl, 2,3,4,5,6-pentahydroxyhexyl, 1,1-bis(hydroxymethyl)ethyl, 2-(2-hydroxyethoxy)B Base, 2-methoxyethyl, 1-methyl-2-hydroxyethyl, 3-hydroxypropyl, 3-methoxypropyl, 1,1-bis(hydroxymethyl)-2-hydroxyethyl a hydrocarbon group having a total carbon number of 1 to 8 substituted by 1 to 6 groups selected from a hydroxyl group, a hydroxyalkoxy group and an alkoxy group.

特佳係氫原子,或亦可取代有由甲基、2-羥基乙基、1,1-二甲基-2-羥基乙基、1,1-雙(羥基甲基)乙基、2-(2-羥基乙氧基)乙基等之羥基及羥基烷氧基所選擇之1~3個的烷基。 Particularly preferred is a hydrogen atom, or may be substituted by methyl, 2-hydroxyethyl, 1,1-dimethyl-2-hydroxyethyl, 1,1-bis(hydroxymethyl)ethyl, 2- One or three alkyl groups selected from the group consisting of a hydroxyl group such as (2-hydroxyethoxy)ethyl group and a hydroxyalkoxy group.

作為一般式(1)所示之神經胺醇,較佳係下述一般式(2)所示之天然來源之神經胺醇或同構造的合成物。 The neuroamine alcohol represented by the general formula (1) is preferably a neurolamine of natural origin or a composition of the same structure represented by the following general formula (2).

(式中,R7表示亦可取代有羥基之碳數7~19之直鏈、分枝鏈或環狀的飽和或不飽和的烴基;Y1表示亞甲基或次甲基;X5、X6及X7分別獨立表示氫原子、羥基或乙醯氧基;X8表示氫原子,或者與相鄰接之氧原子一起形成側氧基(但,在Y1為次甲基時,X5與X6之任 一者為氫原子、另一者不存在;在X8形成側氧基時,X7不存在);R8表示羥基甲基或乙醯氧基甲基;a個之R1分別獨立為氫原子或甲脒基,或者表示亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~4之直鏈或分枝鏈的飽和或不飽和的烴基;a表示2或3之數;虛線部表示亦可為不飽和鍵)。 (wherein R 7 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group which may also have a hydroxyl group of 7 to 19; Y 1 represents a methylene group or a methine group; X 5 , X 6 and X 7 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 8 represents a hydrogen atom or forms a pendant oxy group together with an adjacent oxygen atom (however, when Y 1 is a methine group, X) Any of 5 and X 6 is a hydrogen atom, the other is absent; when X 8 forms a pendant oxy group, X 7 is absent); R 8 represents a hydroxymethyl group or an ethoxymethyloxy group; R 1 is independently a hydrogen atom or a fluorenyl group, or a straight chain or a fraction having a total carbon number of 1 to 4 which may have a substituent selected from a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethoxy group. A saturated or unsaturated hydrocarbon group of a branched chain; a represents a number of 2 or 3; a dotted line represents an unsaturated bond).

於此作為R7,較佳係碳數7~19之直鏈、分枝鏈或環狀的飽和或不飽和的烴基,特佳係碳數13~15之直鏈的飽和或不飽和的烴基。a較佳為2,R1分別獨立為氫原子、或碳數1~4之直鏈或分枝鏈的烷基。 Here, as R 7 , a linear, branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 7 to 19 is preferred, and a linear saturated or unsaturated hydrocarbon group having a carbon number of 13 to 15 is particularly preferred. . a is preferably 2, and R 1 is independently a hydrogen atom or a linear or branched alkyl group having 1 to 4 carbon atoms.

作為一般式(2)所示之天然型神經胺醇,具體而言,可列舉天然之神經胺醇、二氫神經胺醇、植物神經胺醇、sphingadienine、去氫神經胺醇、去氫植物神經胺醇、及此等之N-烷基物(例如N-甲基物)等。 Specific examples of the natural neuroamine alcohol represented by the general formula (2) include natural neuroamine alcohol, dihydroneuraminol, phytohormone, sphingadienine, dehydronephramine, and dehydrogenated autonomic nerves. Amine alcohol, and N-alkyl compounds (such as N-methyl) and the like.

此等神經胺醇可使用天然型(D(+)物)之光學活性物,亦可使用非天然型(L(-)物)之光學活性物,進而亦可使用天然型與非天然型之混合物。上述化合物之相對立體配置,可為天然型之立體配置物,亦可為其以外之非天然型之立體配置物,或可為此等之混合物。 These neuroamines can be used as optical actives of natural type (D(+)), optical actives of non-natural (L(-)), and natural and non-natural. mixture. The relative three-dimensional arrangement of the above compounds may be a natural type of three-dimensional arrangement, or a non-natural type of three-dimensional arrangement other than the above, or a mixture thereof.

特佳係PHYTOSPHINGOSINE(INCI名;第八版)及下式所表示者。 It is represented by PHYTOSPHINGOSINE (INCI name; eighth edition) and the following formula.

[化4] [Chemical 4]

(式中,m表示5~17,l表示1~13。) (where m represents 5 to 17, and l represents 1 to 13.)

此等可為來自天然之萃取物或合成物的任一種,亦可使用市售物。作為天然型神經胺醇之市售物,可列舉例如D-Sphingosine(4-Sphingenine)(SIGMA-ALDRICH公司)、DS-phytosphingosine(DOOSAN公司)、phytosphingosine(Cosmo Pharma公司)。 These may be any of natural extracts or compositions, and commercially available materials may also be used. Examples of commercially available products of natural neuroamine alcohol include D-Sphingosine (4-Sphingenine) (SIGMA-ALDRICH), DS-phytosphingosine (DOOSAN), and phytosphingosine (Cosmo Pharma).

作為此等神經胺醇的鹽,可列舉麩胺酸、天冬胺酸等之 酸性胺基酸鹽;精胺酸等之鹼性胺基酸鹽;磷酸、鹽酸等之無機酸鹽;醋酸等之單羧酸鹽;琥珀酸等之二羧酸鹽;檸檬酸、乳酸、蘋果酸等之氧基羧酸鹽等;較佳係由此等中選擇之1種或2種以上。 Examples of the salt of such a neuroamine alcohol include glutamic acid and aspartic acid. Acidic amino acid salt; basic amine acid salt of arginine acid; inorganic acid salt of phosphoric acid, hydrochloric acid, etc.; monocarboxylic acid salt of acetic acid or the like; dicarboxylic acid salt of succinic acid or the like; citric acid, lactic acid, apple An oxycarboxylate such as an acid or the like; preferably one or two or more selected from the above.

另外,成分(A)之化合物中,作為離子性界面活性劑,可列舉陰離子界面活性劑、陽離子界面活性劑、兩性界面活性劑。 Further, among the compounds of the component (A), examples of the ionic surfactant include an anionic surfactant, a cationic surfactant, and an amphoteric surfactant.

作為陰離子界面活性劑,可列舉例如月桂酸鈉、軟脂酸鉀、硬脂酸精胺酸等之碳數12~22之脂肪酸或其鹽;月桂基硫酸鈉、月桂基硫酸鉀等之碳數12~22之烷基硫酸酯或其鹽;聚氧乙烯月桂基硫酸三乙醇胺等之碳數12~22之烷基醚硫酸酯或其鹽;月桂醯基肌胺酸鈉等之N-碳數12~22之醯基肌胺酸或其鹽;單硬脂基磷酸鈉等之碳數12~22之烷基磷酸或其鹽;聚氧乙烯油基醚磷酸鈉、聚氧乙烯硬脂基醚磷酸鈉等之聚氧乙烯碳數12~22之烷基醚磷酸或其鹽;二-2-乙基己基磺酸基琥珀酸鈉等之碳數12~24之二烷基磺酸基琥珀酸或其鹽;N-硬脂醯基-N-甲基牛磺酸鈉等之碳數12~22之N-烷醯基甲基牛磺酸或其鹽、二月桂醯基麩胺酸鈉、N-月桂醯基麩胺酸單鈉、N-硬脂醯基-L-麩胺酸鈉、N-硬脂醯基-L-麩胺酸精胺酸、N-硬脂醯基麩胺酸鈉、N-肉豆蔻醯基-L-麩胺酸鈉等之N-碳數12~22之醯基麩胺酸或其鹽等。 Examples of the anionic surfactant include fatty acids having a carbon number of 12 to 22 such as sodium laurate, potassium palmitate, and stearic acid, or a salt thereof; carbon number of sodium lauryl sulfate and potassium lauryl sulfate; Alkyl sulfate of 12 to 22 or a salt thereof; alkyl ether sulfate of 12 to 22 carbon atoms such as polyoxyethylene lauryl sulfate triethanolamine or the like; or N-carbon number of sodium lauryl sarcosinate 12~22 thioglycolic acid or its salt; sodium monostearate or the like having 12 to 22 carbonic acid or its salt; polyoxyethylene oleyl ether phosphate, polyoxyethylene stearyl ether a polyoxyethylene having a carbon number of 12 to 22 such as sodium phosphate or a salt thereof; a dialkylsulfonic acid succinic acid having a carbon number of 12 to 24 such as di-2-ethylhexylsulfosuccinate sodium succinate Or a salt thereof; N-alkylmercaptomethyl taurine or a salt thereof having a carbon number of 12 to 22 such as N-stearyl sulfonyl-N-methyl taurate or sodium, sodium lauryl glutamate, N-lauric acid glutamic acid monosodium, N-stearyl sulfhydryl-L-glutamate, N-stearyl sulfhydryl-L-glutamic acid arginine, N-stearyl glutamic acid N-carbon number 12 to 22 thiol glutamic acid such as sodium, N-myristyl-L-glutamate or the like Salt.

另外,作為陽離子界面活性劑,較佳為四級銨鹽,可列舉例如氯化硬脂基三甲基銨、氯化月桂基三甲基胺等之氯化烷基三甲基銨、氯化二烷基二甲基銨、氯化三烷基甲基銨、烷基胺鹽等。 Further, as the cationic surfactant, a quaternary ammonium salt is preferred, and examples thereof include alkyltrimethylammonium chloride such as chlorinated stearyltrimethylammonium chloride and lauryltrimethylamine chloride, and chlorination. Dialkyldimethylammonium chloride, trialkylmethylammonium chloride, alkylamine salt, and the like.

再者,作為兩性界面活性劑,可列舉烷基二甲基氧化胺、烷基羧基甜菜鹼、烷基磺酸基甜菜鹼、醯胺胺基酸鹽、烷基醯胺丙基甜菜鹼,特佳為烷基醯胺丙基甜菜鹼。 Further, examples of the amphoteric surfactant include alkyl dimethyl amine oxide, alkyl carboxy betaine, alkyl sulfobetaine, guanamine amino acid salt, and alkyl guanamine propyl betaine. Preferably, the alkyl amidinopropyl betaine.

作為成分(A),由乳化穩定性的觀點而言,較佳為神經胺 醇鹽及陰離子界面活性劑。 As the component (A), from the viewpoint of emulsion stability, a neuroamine is preferred. Alkoxide and anionic surfactant.

另外,作為陰離子界面活性劑,較佳係脂肪酸或其鹽以外者,更佳係由聚氧乙烯碳數12~22之烷基醚磷酸或其鹽、碳數12~22之N-烷醯基甲基牛磺酸鈉、N-碳數12~22之醯基麩胺酸鹽所選擇之1種或2種以上;由使用感的觀點而言,更佳為N-碳數12~22之醯基麩胺酸或其鹽。作為N-碳數12~22之醯基麩胺酸鹽,較佳為N-硬脂醯基-L-麩胺酸鹽,更佳為N-硬脂醯基-L-麩胺酸精胺酸鹽、N-硬脂醯基-L-麩胺酸鉀鹽。 Further, as the anionic surfactant, it is preferably a fatty acid or a salt thereof, more preferably an alkyl ether phosphate having a polyoxyethylene carbon number of 12 to 22 or a salt thereof, or an N-alkyl fluorenyl group having 12 to 22 carbon atoms. One or more selected from the group consisting of sodium methyl taurate and N-carbon number 12 to 22 thiol glutamate; more preferably N-carbon number 12 to 22 from the viewpoint of use sensation Mercaptoglutamic acid or a salt thereof. As the N-carbon number 12 to 22 thiol glutamate, preferably N-stearyl sulfhydryl-L-glutamate, more preferably N-stearyl sulfhydryl-L-glutamic acid spermine Acid salt, N-stearyl sulfhydryl-L-glutamic acid potassium salt.

成分(A)可單獨使用1種或組合2種以上而使用。例如可將硬脂醯基麩胺酸、聚氧乙烯(4)月桂基醚磷酸鈉、植物神經胺醇分別單獨使用。又,可將硬脂醯基麩胺酸與聚氧乙烯(4)月桂基醚磷酸鈉組合使用,亦可將二月桂醯基麩胺酸鈉與硬脂醯基麩胺酸組合使用。 The component (A) may be used alone or in combination of two or more. For example, stearyl glutamic acid, polyoxyethylene (4) sodium lauryl ether phosphate, and phytohormone can be used separately. Further, stearic acid glutamic acid may be used in combination with polyoxyethylene (4) sodium lauryl ether phosphate, and sodium dilaurate glutamate may be used in combination with stearyl glutamic acid.

成分(A)之化合物可單獨或組合2種以上使用。成分(A)之含量係表示去除了對離子之化合物的含量,由可將後述各成分穩定分散、得到無黏瘩之使用感的觀點而言,於全組成物中為0.01質量%以上、較佳為0.05質量%以上、更佳為0.1質量%以上,且為10質量%以下、較佳為5質量%以下、更佳為3質量%以下。又,成分(A)之含量,係以去除了對離子之化合物的含量計,於全組成物中為0.01~10質量%、較佳為0.05~5質量%、更佳為0.1~3質量%。 The compound of the component (A) may be used alone or in combination of two or more. The content of the component (A) is a content of the compound in which the ion is removed, and is 0.01% by mass or more in the total composition, from the viewpoint that the components described below can be stably dispersed to obtain a feeling of use without stickiness. It is preferably 0.05% by mass or more, more preferably 0.1% by mass or more, and is 10% by mass or less, preferably 5% by mass or less, and more preferably 3% by mass or less. Further, the content of the component (A) is 0.01 to 10% by mass, preferably 0.05 to 5% by mass, and more preferably 0.1 to 3% by mass based on the total amount of the compound to which the ion is removed. .

[成分(B)] [ingredient (B)]

本發明所使用之成分(B),為二直鏈脂肪酸甘油酯及二直鏈脂肪酸去水山梨醇酯,較佳係由碳數12~22之二直鏈脂肪酸甘油酯及碳數12~22之二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合 物。又,所謂2種以上之化合物,係例如即使是分類為二直鏈脂肪酸甘油酯的化合物,若構造相異,則仍視為2種以上。 The component (B) used in the present invention is a di-linear fatty acid glyceride and a di-linear fatty acid sorbitan ester, preferably a linear fatty acid glyceride having a carbon number of 12 to 22 and a carbon number of 12 to 22 One or two or more compounds selected from the two-chain fatty acid sorbitan ester Things. In addition, the compound of two or more types is, for example, a compound classified into a two-chain fatty acid glyceride, and two or more types are considered to have different structures.

作為碳數12~22之二直鏈脂肪酸甘油酯,可列舉甘油二月桂酸酯、甘油二肉豆蒄酸酯、甘油二軟脂酸酯、甘油二硬脂酸酯、甘油二蘿酸酯、甘油二油酸酯、甘油二異硬脂酸酯等。 Examples of the linear fatty acid glyceride having 12 to 22 carbon atoms include glycerin dilaurate, glyceryl dimyristate, glyceryl distearate, glyceryl distearate, and glyceryl dicarboxylic acid ester. Diglyceride, glyceryl diisostearate, and the like.

作為碳數12~22之二直鏈脂肪酸去水山梨醇酯,可列舉例如二月桂酸去水山梨醇酯、二肉豆蒄酸去水山梨醇酯、二軟脂酸去水山梨醇酯、二硬脂酸去水山梨醇酯、二蘿酸去水山梨醇酯、二油酸去水山梨醇酯。 Examples of the linear fatty acid sorbitan ester having 12 to 22 carbon atoms include, for example, sorbitan dilaurate, sorbitan dimyristate, sorbitan distearate, Sorbitan distearate, sorbitan disorbate, sorbitan dioleate.

此等之中,由保存穩定性的觀點而言,較佳為二硬脂酸甘油酯、二硬脂酸去水山梨醇酯。 Among these, from the viewpoint of storage stability, glyceryl distearate and sorbitan distearate are preferred.

本發明所使用之成分(B),係藉由與成分(A)與後述成分(C)組合,而形成片層狀構造。 The component (B) used in the present invention is combined with the component (A) and the component (C) described later to form a sheet-like structure.

成分(B)之含量由穩定性及塗佈時之黏瘩的觀點而言,於全組成中較佳為0.01質量%以上、更佳為0.05質量%以上、進而更佳為0.1質量%以上,且較佳為10質量%以下、更佳為8質量%以下、進而更佳為5質量%以下。又,成分(B)之含量較佳係於全組成中為0.01~10質量%、更佳為0.05~8質量%、進而更佳為0.1~5質量%。 The content of the component (B) is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and still more preferably 0.1% by mass or more in terms of stability and adhesion at the time of coating. It is preferably 10% by mass or less, more preferably 8% by mass or less, and still more preferably 5% by mass or less. Further, the content of the component (B) is preferably from 0.01 to 10% by mass, more preferably from 0.05 to 8% by mass, even more preferably from 0.1 to 5% by mass, based on the total composition.

[成分(C)] [ingredient (C)]

本發明所使用之成分(C),係由一般式(3)所示之化合物、碳數12~22之醇、碳數12~22之單脂肪酸甘油酯、碳數12~22之單烷基甘油醚及碳數12~22之單脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物。 The component (C) used in the present invention is a compound represented by the general formula (3), an alcohol having 12 to 22 carbon atoms, a monoglyceride having 12 to 22 carbon atoms, and a monoalkyl group having 12 to 22 carbon atoms. One or two or more compounds selected from the group consisting of glyceryl ether and dicole sorbitan ester having 12 to 22 carbon atoms.

(式中,R11表示亦可取代有羥基、羰基或胺基的碳數4~30之直鏈、分枝鏈或環狀之飽和或不飽和的烴基或氫原子;Z表示亞甲基、次甲基或氧原子;X11、X12及X13分別獨立表示氫原子、羥基或乙醯氧基;X14表示氫原子、乙醯基或甘油基,或與相鄰接之氧原子一起形成側氧基(但,在Z為次甲基時,X11與X12之任一者為氫原子、另一者不存在;在X14形成側氧基時,X13不存在);R12及R13分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;R14表示亦可取代有羥基、羰基或胺基之於主鏈亦可具有醚鍵、酯鍵或醯胺鍵的碳數5~60之直鏈、分枝鏈或環狀之飽和或不飽和的烴基;R15表示氫原子,或亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~30之直鏈或分枝鏈的飽和或不飽和的烴基(但,在R11為氫原子、Z為氧原子時,R15為總碳數10~30之烴基;在R11為烴基時,R15為總碳數1~8之烴基);虛線部表示亦可為不飽和鍵)。 (wherein R 11 represents a straight-chain, branched chain or cyclic saturated or unsaturated hydrocarbon group or hydrogen atom which may have a hydroxyl group, a carbonyl group or an amine group of 4 to 30; Z represents a methylene group, a methine or an oxygen atom; X 11 , X 12 and X 13 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 14 represents a hydrogen atom, an ethyl fluorenyl group or a glyceryl group, or together with an adjacent oxygen atom Forming a pendant oxy group (however, when Z is a methine group, either of X 11 and X 12 is a hydrogen atom, the other is absent; when X 14 forms a pendant oxy group, X 13 is absent); 12 and R 13 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; and R 14 represents a hydroxyl group, a carbonyl group or an amine group which may be substituted with a hydroxyl group, an ester bond or an anthracene. a linear, branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 5 to 60; R 15 represents a hydrogen atom, or may have a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethyl group. a saturated or unsaturated hydrocarbon group of a linear or branched chain having a total carbon number of 1 to 30, which is a substituent selected from the oxy group (however, when R 11 is a hydrogen atom and Z is an oxygen atom, R 15 is a total carbon number) 10~30 The hydrocarbon group; when R 11 is a hydrocarbon group, R 15 is a hydrocarbon group having a total carbon number of 1 to 8); the dotted line portion may also be an unsaturated bond).

尚且,所謂2種以上之化合物,係例如即使是分類為一般式(3)的化合物,若構造相異,則仍視為2種以上。 In addition, for example, even if it is a compound classified into the general formula (3), the compound of two or more types is considered to be two or more types.

式中,R11表示亦可取代有羥基、羰基或胺基之碳數4~30、較佳係亦可取代有羥基之碳數7~22之直鏈、分枝鏈或環狀的飽和或不飽和的烴基或氫原子。 Wherein R 11 represents a linear, branched or cyclic saturated or substituted carbon group having a hydroxyl group, a carbonyl group or an amine group of 4 to 30, preferably substituted with a hydroxyl group having 7 to 22 carbon atoms; An unsaturated hydrocarbon group or a hydrogen atom.

Z表示亞甲基(CH2)、次甲基(CH)或氧原子之任一種。 Z represents any one of a methylene group (CH 2 ), a methine group (CH) or an oxygen atom.

X11、X12及X13分別獨立表示氫原子、羥基或乙醯氧基;特佳係X11、X12及X13中0~1個為羥基、剩餘為氫原子。在Z為次甲基時,X11與X12之任一者為氫原子、另一者不存在。又,X14較佳為氫原子或甘油基。 X 11 , X 12 and X 13 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; and particularly preferably 0 to 1 of X 11 , X 12 and X 13 are a hydroxyl group, and the remainder is a hydrogen atom. When Z is a methine group, either of X 11 and X 12 is a hydrogen atom and the other is absent. Further, X 14 is preferably a hydrogen atom or a glyceryl group.

R12及R13分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;較佳R12為氫原子或羥基甲基,較佳R13為氫原子。 R 12 and R 13 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; preferably, R 12 is a hydrogen atom or a hydroxymethyl group, and preferably R 13 is a hydrogen atom.

R14表示亦可取代有羥基、羰基或胺基之於主鏈亦可具有醚鍵、酯鍵或醯胺鍵的碳數5~60之直鏈、分枝鏈或環狀之飽和或不飽和的烴基。較佳可列舉亦可取代有羥基或胺基之碳數5~35之直鏈、分枝鏈或環狀的飽和或不飽和的烴基,或於該烴基之ω位上、亦可取代有羥基之碳數8~22之直鏈、分枝或環狀的飽和或不飽和的脂肪酸經酯鍵結或醯胺鍵結者。作為鍵結之脂肪酸,較佳係異硬脂酸、12-羥基硬脂酸或亞麻油酸。 R 14 represents a linear, branched or cyclic saturated or unsaturated group having a carbon number of 5 to 60 which may have a hydroxyl group, a carbonyl group or an amine group and may have an ether bond, an ester bond or a guanamine bond in the main chain. Hydrocarbyl group. Preferably, a saturated or unsaturated hydrocarbon group having a linear or branched chain or a cyclic carbon number of 5 to 35 having a hydroxyl group or an amine group may be substituted, or a hydroxyl group may be substituted at the ω position of the hydrocarbon group. A linear, branched or cyclic saturated or unsaturated fatty acid having a carbon number of 8 to 22 is bonded via an ester bond or a guanamine bond. As the fatty acid to be bonded, it is preferably isostearic acid, 12-hydroxystearic acid or linoleic acid.

R15表示氫原子,或亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~30之直鏈或分枝鏈的飽和或不飽和的烴基。R11為氫原子、Z為氧原子時,R15為總碳數10~30之烴基。又,R11為烴基時,R15為總碳數1~8之烴基。特佳係氫原子,或亦可取代有由羥基及羥基烷氧基、烷氧基所選擇之1~3個的總碳數1~8之烴基。於此,作為羥基烷氧基及烷氧基,較佳係碳數1~7者。 R 15 represents a hydrogen atom or a saturated or unsaturated chain of a linear or branched chain having a total carbon number of 1 to 30 which may have a substituent selected from a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethoxylated group. Hydrocarbyl group. When R 11 is a hydrogen atom and Z is an oxygen atom, R 15 is a hydrocarbon group having a total carbon number of 10 to 30. Further, when R 11 is a hydrocarbon group, R 15 is a hydrocarbon group having a total carbon number of 1 to 8. It is particularly preferably a hydrogen atom, or may be substituted with one to three hydrocarbon groups having a total carbon number of 1 to 8 selected from a hydroxyl group, a hydroxyalkoxy group or an alkoxy group. Here, the hydroxyalkoxy group and the alkoxy group are preferably those having 1 to 7 carbon atoms.

作為一般式(3)所示之化合物,較佳係由下述一般式(4)或(5)所示之腦醯胺。 The compound represented by the general formula (3) is preferably a ceramide which is represented by the following general formula (4) or (5).

(I)一般式(4)所示之天然來源之腦醯胺或同構造的合成物及其衍生物(以下記載為天然型腦醯胺)。 (I) Ceramide or a synthetic compound of the same origin and a derivative thereof (hereinafter referred to as natural ceramide) represented by the general formula (4).

[化6] [Chemical 6]

(式中,R21表示亦可取代有羥基之碳數7~19之直鏈、分枝鏈或環狀的飽和或不飽和的烴基;Z1表示亞甲基或次甲基;X15、X16及X17分別獨立表示氫原子、羥基或乙醯氧基;X18表示氫原子,或者與相鄰接之氧原子一起形成側氧基(但,在Z1為次甲基時,X15與X16之任一者為氫原子、另一者不存在;在X18形成側氧基時,X17不存在);R22表示羥基甲基或乙醯氧基甲基;R23表示氫原子,或碳數1~4之烷基;R24表示亦可取代有羥基之碳數5~30的直鏈、分枝或環狀的飽和或不飽和的烴基,或於該烷基之ω末端,亦可取代有羥基之碳數8~22的直鏈或分枝鏈的飽和或不飽和的脂肪酸經酯鍵結者;虛線部表示亦可為不飽和鍵)。 (wherein R 21 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group which may also have a hydroxyl group of 7 to 19; Z 1 represents a methylene group or a methine group; X 15 , X 16 and X 17 each independently represent a hydrogen atom, a hydroxyl group or an ethyloxy group; X 18 represents a hydrogen atom or forms a pendant oxy group together with an adjacent oxygen atom (however, when Z 1 is a methine group, X) Any of 15 and X 16 is a hydrogen atom, the other is absent; when X 18 forms a pendant oxy group, X 17 is absent; R 22 represents a hydroxymethyl group or an ethoxymethyloxy group; and R 23 represents a hydrogen atom, or an alkyl group having 1 to 4 carbon atoms; R 24 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group which may be substituted with a hydroxyl group having 5 to 30 carbon atoms, or The ω terminal may also be substituted with a linear or branched chain saturated or unsaturated fatty acid having a hydroxyl group of 8 to 22 via an ester bond; the dotted line may also be an unsaturated bond).

較佳可列舉R21為碳數7~19、更佳為碳數13~15之直鏈烷基;R24為亦可取代有羥基之碳數9~27之直鏈烷基或亞麻油酸經酯鍵結之碳數9~27之直鏈烷基的化合物。又,較佳係X18表示氫原子,或與氧原子一起形成側氧基者。特佳係作為R24,為二十三基、1-羥基十五基、1-羥基二十三基、十七基、1-羥基十一基、於ω位亞麻油酸經酯鍵結的二十九基。 Preferably, R 21 is a linear alkyl group having a carbon number of 7 to 19, more preferably 13 to 15 carbon atoms; and R 24 is a linear alkyl group or linoleic acid having a carbon number of 9 to 27 which may be substituted with a hydroxyl group. A compound of a linear alkyl group having an ester number of 9 to 27 carbon atoms. Further, it is preferred that X 18 represents a hydrogen atom or forms a pendant oxygen group together with an oxygen atom. Particularly preferred as R 24 , which is a Twenty-three base, a 1-hydroxyl-15-yl group, a 1-hydroxyl-trisyl group, a heptadecyl group, a 1-hydroxyundecyl group, and is ester-bonded to the ω-linolenic acid. Twenty-nine base.

作為天然型腦醯胺,具體的例示可列舉神經胺醇、二氫神經胺醇、植物神經胺醇或sphingadienine經醯胺化的腦醯胺Type1~7(例如J.Lipid Res.,24:759(1983)之圖2、及J.Lipid.Res.,35:2069(1994)之圖4記載的豬或人的腦醯胺)。 Specific examples of the natural ceramide may be exemplified by ceramide, ceramide, or sphingadienine, and sphingadienine, for example, J. Lipid Res., 24:759 Figure 2 of (1983) and porcine ceramide of pig or human as depicted in Figure 4 of J. Lipid. Res., 35:2069 (1994).

進而亦包括此等之N-烷基物(例如N-甲基物)。 Further included are N-alkyl species (e.g., N-methyl).

此等腦醯胺可使用天然型(D(-)物)之光學活性物,亦可使用非天然型(L(+)物)之光學活性物,進而亦可使用天然型與非天然型之混合物。上述化合物之相對立體配置,可為天然型之立體配置物,亦可為其以外之非天然型之立體配置物,或可為此等之混合物。特佳係CERAMIDE1、CERAMIDE2、CERAMIDE3、CERAMIDE5、CERAMIDE6II之化合物(以上為INCI,第八版)及下式所示者。 These ceramides may be optically active (D(-)), or optically active (L(+)), and natural and non-natural. mixture. The relative three-dimensional arrangement of the above compounds may be a natural type of three-dimensional arrangement, or a non-natural type of three-dimensional arrangement other than the above, or a mixture thereof. Tejia is the compound of CERAMIDE1, CERAMIDE2, CERAMIDE3, CERAMIDE5, CERAMIDE6II (the above is INCI, the eighth edition) and the following formula.

此等可為來自天然之萃取物及合成物的任一種,亦可使用市售物。作為此種天然型腦醯胺之市售物,可列舉Ceramide I、Ceramide III、Ceramide IIIA、Ceramide IIIB、Ceramide IIIC、Ceramide VI(以上為Cosmo Pharma公司)、Ceramide TIC-001(高砂香料公司)、CERAMIDE II(Quest International公司)、DS-Ceramide VI、DS-CLA-Phytoceramide、C6-Phytoceramide、DS-ceramide Y3S(DOOSAN 公司)、CERAMIDE 2(Sederma公司)。 These may be any of natural extracts and compositions, and commercially available products may also be used. As a commercial product of such natural ceramide, Ceramide I, Ceramide III, Ceramide IIIA, Ceramide IIIB, Ceramide IIIC, Ceramide VI (above, Cosmo Pharma), Ceramide TIC-001 (High Sand Spice Co., Ltd.), CERAMIDE II (Quest International), DS-Ceramide VI, DS-CLA-Phytoceramide, C6-Phytoceramide, DS-ceramide Y3S (DOOSAN Company), CERAMIDE 2 (Sederma).

(II)一般式(5)所示之模擬型腦醯胺。 (II) Simulated brain ceramide represented by the general formula (5).

(式中,R25表示亦可取代有羥基之碳數10~22之直鏈、分枝鏈或環狀之飽和或不飽和的烴基或氫原子;X19為表示氫原子、乙醯基或甘油基;R26表示亦可取代有羥基或胺基之碳數5~22之直鏈、 分枝鏈或環狀之飽和或不飽和的烴基,或於該烴基之ω末端,亦可取代有羥基之碳數8~22之直鏈或分枝鏈之飽和或不飽和脂肪酸經酯鍵結者;R27表示氫原子,或亦可取代有羥基、羥基烷氧基、烷氧基或乙醯氧基之總碳數1~30的烷基)。 (wherein R 25 represents a saturated or unsaturated hydrocarbon group or a hydrogen atom which may also be substituted with a linear, branched or cyclic ring having 10 to 22 carbon atoms; and X 19 represents a hydrogen atom, an ethylene group or a glyceryl group; R 26 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group having 5 to 22 carbon atoms or a hydroxyl group, or may be substituted at the ω end of the hydrocarbon group. A saturated or unsaturated fatty acid having a linear or branched chain of 8 to 22 carbon atoms of a hydroxyl group is ester-bonded; R 27 represents a hydrogen atom, or may be substituted with a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an ethyl hydrazine. The total number of carbons of the oxy group is from 1 to 30 alkyl groups.

作為R26,較佳係壬基、十三基、十五基、於ω位亞麻油酸經酯鍵結的十一基、於ω位亞麻油酸經酯鍵結之十五基、於ω位12-羥基硬脂酸經酯鍵結之十五基、於ω位甲基分枝異硬脂酸經醯胺鍵結的十一基。 R 26 is preferably a fluorenyl group, a thirteen group, a fifteen group, an eleven group bonded to the ω linoleic acid via an ester, and a fifteen group bonded to the ω linoleic acid via an ester. The eleven-group of the 12-hydroxystearic acid ester-bonded fifteen-group, at the ω-position methyl-branched isostearic acid via a guanamine linkage.

較佳係在R25為氫原子時,R27為亦可取代有羥基、羥基烷氧基、烷氧基或乙醯氧基之總碳數10~30、較佳係總碳數12~20之烷基;於R25為亦可取代有羥基之碳數10~22之直鏈、分枝鏈或環狀之飽和或不飽和的烴基時,R27表示氫原子,或表示亦可取代有羥基、羥基烷氧基、烷氧基或乙醯氧基之總碳數1~8的烷基。R27之羥基烷氧基或烷氧基較佳為碳數1~7者。 Preferably, when R 25 is a hydrogen atom, R 27 is a total of 10 to 30, preferably a total carbon number of 12 to 20, which may be substituted with a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an ethyloxy group. The alkyl group; when R 25 is a linear or branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 10 to 22, R 27 represents a hydrogen atom, or An alkyl group having a total carbon number of 1 to 8 of a hydroxyl group, a hydroxyalkoxy group, an alkoxy group or an ethoxylated group. The hydroxyalkoxy group or alkoxy group of R 27 is preferably a carbon number of 1 to 7.

作為一般式(5),較佳係以R25為十六基、X19為氫原子、R26為十五基、R27為羥基乙基者;R25為十六基、X19為氫原子、R26為壬基、R27為羥基乙基者的類似型腦醯胺;更佳係一般式(5)之R25為十 六基、X19為為氫原子、R26為十五基、R27為羥基乙基者的(N-(十六醯氧基羥基丙基)-N-羥基乙基十六醯胺)。 As a general formula (5), R 25 is a hexadecanyl group, X 19 is a hydrogen atom, R 26 is a fifteen group, and R 27 is a hydroxyethyl group; R 25 is a hexadecyl group, and X 19 is hydrogen. a similar type of ceramide, wherein R 26 is a fluorenyl group and R 27 is a hydroxyethyl group; more preferably, R 25 of the general formula (5) is a hexadecanyl group, X 19 is a hydrogen atom, and R 26 is a fifteen group. (N-(hexadecyloxyhydroxypropyl)-N-hydroxyethylhexadecaneamine) wherein R 27 is a hydroxyethyl group.

成分(C)中作為一般式(3)所示的化合物,可自天然型腦醯胺及模擬型腦醯胺選擇1種或2種以上使用。 The compound represented by the general formula (3) in the component (C) may be used alone or in combination of two or more kinds selected from the group consisting of natural ceramide and simulated ceramide.

作為成分(C)之碳數12~22之醇,可列舉例如肉豆蒄醇、鯨蠟醇、硬脂醇、蘿醇、油醇等。此等之中,較佳係具有直鏈烷基者,特佳係碳數16~18醇,更佳為鯨蠟醇、硬脂醇。 Examples of the alcohol having 12 to 22 carbon atoms of the component (C) include myristyl alcohol, cetyl alcohol, stearyl alcohol, alditol, and oleyl alcohol. Among them, those having a linear alkyl group are preferred, and the carbon number is preferably 16 to 18 alcohols, more preferably cetyl alcohol or stearyl alcohol.

作為成分(C)之碳數12~22之單脂肪酸甘油酯,可列舉例如甘油單月桂酸酯、甘油單肉豆蔻酸酯、甘油單軟脂酸酯、甘油單硬脂酸酯、甘油單蘿酸酯、甘油單油酸酯、甘油單異硬脂酸酯等。此等之中,較佳為甘油單蘿酸酯、甘油單硬脂酸酯、甘油單軟脂酸酯,特佳為甘油單蘿酸酯。 Examples of the mono-fatty acid glyceride having 12 to 22 carbon atoms of the component (C) include glycerol monolaurate, glycerin monomyristate, glycerin monocaprate, glyceryl monostearate, and glycerol mono An acid ester, glycerin monooleate, glycerol monoisostearate or the like. Among these, glycerin monooleate, glycerin monostearate, and glycerin monostearate are preferred, and glycerol monocronate is particularly preferred.

作為成分(C)之碳數12~22之單烷基甘油醚,可列舉例如單癸基甘油醚、單月桂基甘油醚、單肉豆蔻基甘油醚、單鯨蠟基甘油醚、單硬脂基甘油醚、單廿二基甘油醚等。 Examples of the monoalkyl glyceryl ether having 12 to 22 carbon atoms of the component (C) include monodecyl glyceryl ether, monolauryl glyceryl ether, monomyristyl glyceryl ether, monocetyl glyceryl ether, and monostearyl. Glyceryl ether, monoterpene diglyceryl ether, and the like.

作為成分(C)之碳數12~22之單脂肪酸去水山梨醇酯,可列舉例如單月桂酸去水山梨醇酯、單肉豆蒄酸去水山梨醇酯、單軟脂酸去水山梨醇酯、單硬脂酸去水山梨醇酯、單蘿酸去水山梨醇酯等。 The mono-fatty acid sorbitan ester having a carbon number of 12 to 22 as the component (C) may, for example, be sorbitan monolaurate, sorbitan monomyristate or sorbitan monostearate. Alcohol esters, sorbitan monostearate, sorbitan monostearate, and the like.

此等之中,作為成分(C),由長期保存穩定性的觀點而言,較佳為碳數14~22之醇、碳數14~22之單脂肪酸甘油酯、碳數14~22之單烷基甘油醚、碳數14~22之單脂肪酸去水山梨醇酯。更佳為碳數16~22醇、碳數16~22之單脂肪酸甘油酯。 Among these, as the component (C), from the viewpoint of long-term storage stability, an alcohol having 14 to 22 carbon atoms, a monoglyceride having 14 to 22 carbon atoms, and a single carbon number of 14 to 22 are preferable. Alkyl glyceryl ether, slaked sorbitan ester of a single fatty acid having 14 to 22 carbon atoms. More preferably, it is a single fatty acid glyceride having a carbon number of 16 to 22 alcohols and a carbon number of 16 to 22.

本發明所使用之成分(C),係藉由與成分(A)與成分(B)組合,而形成片層狀構造。 The component (C) used in the present invention is combined with the component (A) and the component (B) to form a sheet-like structure.

成分(C)之含量由穩定性、塗佈時之黏瘩較少的觀點而言,於全組成中較佳為0.05質量%以上、更佳為0.1質量%以上、進而更佳為0.5質量%以上,且較佳為15質量%以下、更佳為13質量%以下、進而更佳為10質量%以下。又,成分(C)之含量較佳係於全組成中為0.05~15質量%、更佳為0.1~13質量%、進而更佳為0.5~10質量%。 The content of the component (C) is preferably 0.05% by mass or more, more preferably 0.1% by mass or more, and still more preferably 0.5% by mass in terms of stability and less stickiness at the time of coating. The above is preferably 15% by mass or less, more preferably 13% by mass or less, and still more preferably 10% by mass or less. Further, the content of the component (C) is preferably from 0.05 to 15% by mass, more preferably from 0.1 to 13% by mass, even more preferably from 0.5 to 10% by mass, based on the total composition.

本發明中,重要的是成分(A)、(B)、(C)滿足下述關係:(1)(A)/((B)+(C))之質量比為0.04~1;(2)(B)/((B)+(C))之莫耳分率為0.01~0.45;(3)(B)+(C)構成成分中之1化合物單成分所佔有之最大莫耳分率為0.2~0.8。 In the present invention, it is important that the components (A), (B), and (C) satisfy the following relationship: (1) the mass ratio of (A) / ((B) + (C)) is 0.04 to 1; (B)/((B)+(C)) has a molar fraction of 0.01 to 0.45; (3) (B) + (C) the maximum molar fraction of the single component of the compound It is 0.2~0.8.

(1)(A)/((B)+(C))之質量比係表示成分(A)可使成分(B)、(C)穩定乳化的較佳範圍。又,具有藉靜電性排斥保持由成分(B)、(C)所構成分子的排列的作用。再者,在將本發明之化妝料塗佈於皮膚時,由形成α型構造之皮膜而負責保持成分(E)水的角色、維持被膜之柔軟性而言屬較佳。基於上述觀點,(A)/((B)+(C))之質量比為0.04以上、較佳為0.06以上、更佳為0.09以上,且為1以下、較佳為0.5以下、更佳為0.3以下。又,(A)/((B)+(C))之質量比為0.04~1、較佳為0.06~0.5、更佳為0.09~0.3。 (1) The mass ratio of (A)/((B)+(C)) indicates a preferable range in which the component (A) can stably emulsifie the components (B) and (C). Further, it has an action of retaining the arrangement of molecules composed of the components (B) and (C) by electrostatic repulsion. Further, when the cosmetic of the present invention is applied to the skin, it is preferable to form a film of an α-type structure and to maintain the role of the component (E) water and to maintain the flexibility of the film. From the above viewpoint, the mass ratio of (A)/((B)+(C)) is 0.04 or more, preferably 0.06 or more, more preferably 0.09 or more, and is 1 or less, preferably 0.5 or less, more preferably 0.3 or less. Further, the mass ratio of (A)/((B)+(C)) is 0.04 to 1, preferably 0.06 to 0.5, more preferably 0.09 to 0.3.

(2)(B)/((B)+(C))之莫耳分率係在由成分(B)、(C)所構成分子之排列形成為層狀構造方面較佳。(B)/((B)+(C))之莫耳分率由上述觀點而言,為0.01以上、較佳為0.03以上、更佳為0.04以上,且為0.45以下、較佳為0.4以下、更佳為0.35以下。又,(B)/((B)+(C))之莫耳分率為0.01~0.45、較佳為0.03~0.4、更佳為0.04~0.35。 (2) The molar fraction of (B)/((B)+(C)) is preferably formed in a layered structure in which the molecules composed of the components (B) and (C) are arranged. From the above viewpoints, the molar fraction of (B)/((B)+(C)) is 0.01 or more, preferably 0.03 or more, more preferably 0.04 or more, and is 0.45 or less, preferably 0.4 or less. More preferably, it is 0.35 or less. Further, the molar fraction of (B)/((B)+(C)) is from 0.01 to 0.45, preferably from 0.03 to 0.4, more preferably from 0.04 to 0.35.

(3)(B)+(C)構成成分中之1化合物所佔有之最大莫耳分率,認為係為了使由成分(B)、(C)所構成分子之排列形成為層狀構造、穩定層狀構造所必要者。更詳言之,認為其在形成了層狀構造時,具有抑制成分之結晶化、保持屬於水合固體之α-凝膠構造、維持形成於皮膚上之皮膜之柔軟性的作用。又,保存穩定性亦提升。由上述觀點而言,(B)+(C)構成成分中之1化合物所佔有之最大莫耳分率為0.2以上、較佳為0.3以上,且為0.8以下、較佳為0.78以下。又,(B)+(C)構成成分中之1化合物所佔有之最大莫耳分率為0.2~0.8、較佳為0.3~0.78。 (3) The maximum molar fraction occupied by the compound of (B) + (C) is considered to be a layered structure and stable in order to form the molecules composed of the components (B) and (C). Necessary for layered structure. More specifically, it is considered that when a layered structure is formed, it has an effect of suppressing crystallization of components, maintaining an α-gel structure belonging to a hydrated solid, and maintaining the flexibility of a film formed on the skin. Moreover, the storage stability is also improved. From the above viewpoints, the maximum molar fraction occupied by the compound of the (B) + (C) constituent is 0.2 or more, preferably 0.3 or more, and 0.8 or less, preferably 0.78 or less. Further, the maximum molar fraction of the compound of the (B) + (C) component is 0.2 to 0.8, preferably 0.3 to 0.78.

又,基於同樣觀點,成分(B)與(C)之各別的構成成分,較佳係1種或2種以上之複數的混合物,構成成分(B)與(C)之化合物種類的合計較佳為3種以上。 Further, based on the same viewpoint, the respective constituent components of the components (B) and (C) are preferably one or a mixture of two or more plural components, and the total of the compound species of the component (B) and the component (C) is Good for more than 3 types.

再者,成分(B)、(C)含量中,由保濕效果、及保存穩定性的觀點而言,成分(B)及(C)之合計含量較佳為0.1質量%以上、更佳為0.5質量%以上,且較佳為17質量%以下、更佳為10質量%以下。又,成分(B)及(C)之合計含量較佳為0.1~17質量%、更佳為0.5~10質量%。 In addition, in the content of the components (B) and (C), the total content of the components (B) and (C) is preferably 0.1% by mass or more, and more preferably 0.5, from the viewpoint of the moisturizing effect and the storage stability. The mass% or more is preferably 17% by mass or less, more preferably 10% by mass or less. Further, the total content of the components (B) and (C) is preferably from 0.1 to 17% by mass, more preferably from 0.5 to 10% by mass.

[成分(D)] [ingredient (D)]

本發明所使用之成分(D)的粉體,由持續無黏瘩的觀點而言,平均粒徑為0.1~30μm、較佳為1~20μm。 The powder of the component (D) used in the present invention has an average particle diameter of from 0.1 to 30 μm, preferably from 1 to 20 μm, from the viewpoint of no stickiness.

於此,所謂平均粒徑,係指使用雷射繞射/散射式粒度分佈計(例如堀場製作所公司製,LA-920),由依雷射繞射/散射法所測定之體積基準粒度分佈所算出的中徑。 Here, the average particle diameter is calculated from a volume-based particle size distribution measured by a laser diffraction/scattering method using a laser diffraction/scattering particle size distribution meter (for example, LA-920, manufactured by Horiba, Ltd.). The middle diameter.

作為成分(D)之粉體,若為化妝料中通常使用者則無限制,可適當地使用無機粉體、有機粉體之任一種,其形狀可為球狀、板狀等任一種。粉體之內部構造亦無限制,可使用多孔質、中空、無孔質等之任一種。此等粉體係於15~100℃中,不溶解於水、醇、油劑等。 The powder of the component (D) is not particularly limited as long as it is a user of the cosmetic material, and any of an inorganic powder and an organic powder may be suitably used, and the shape thereof may be any of a spherical shape and a plate shape. The internal structure of the powder is not limited, and any of porous, hollow, and non-porous materials can be used. These powder systems are insoluble in water, alcohol, oil, etc. at 15~100 °C.

作為無機粉體,可列舉例如二氧化矽(矽酸酐)、矽酸鈣、矽酸鎂、雲母、滑石、高嶺土、絹雲母、氧化鈦、氧化鋅、氧化鎂、氧化鋯、碳酸鈣、碳酸鎂、矽酸鎂、硫酸鋇、紅丹、黃氧化鐵、黑氧化鐵、碳黑、錳紫、玻璃珠、沸石、珍珠顏料(紅丹被覆雲母、氧化鈦被覆雲母等)、此等之複合體等。 Examples of the inorganic powder include cerium oxide (phthalic anhydride), calcium citrate, magnesium silicate, mica, talc, kaolin, sericite, titanium oxide, zinc oxide, magnesium oxide, zirconium oxide, calcium carbonate, and magnesium carbonate. , magnesium citrate, barium sulfate, red dan, yellow iron oxide, black iron oxide, carbon black, manganese violet, glass beads, zeolite, pearl pigment (red dan-coated mica, titanium oxide coated mica, etc.), such a complex Wait.

作為有機粉體,可列舉例如苯乙烯樹脂、丙烯酸樹脂、聚烯烴、聚矽氧樹脂、氟樹脂、聚酯、聚醯胺等之熱可塑性樹脂、環氧樹脂、酚樹脂、胺基甲酸乙酯樹脂、進而絲、羊毛、纖維素、澱粉等。 Examples of the organic powder include thermoplastic resins such as styrene resin, acrylic resin, polyolefin, polyoxyxylene resin, fluororesin, polyester, and polyamide, epoxy resin, phenol resin, and ethyl urethane. Resin, further silk, wool, cellulose, starch, and the like.

成分(D)之粉體可使用將表面藉化合物等進行了處理的改質粉體,由均勻分散於α-凝膠被膜的觀點而言,較佳係未經使用了聚矽氧油、脂肪酸金屬鹽等之疏水化處理者。 As the powder of the component (D), a modified powder obtained by treating a surface with a compound or the like can be used. From the viewpoint of being uniformly dispersed in the α-gel film, it is preferred that no polyoxyl oil or fatty acid is used. Hydrophobic treatment of metal salts and the like.

另外,粉體形狀由不易被埋覆於α-凝膠被膜內而表現清爽觸感的觀點而言,更佳為球狀。所謂球狀,具體而言,較佳係具有真球度7成以上的球狀粉體。所謂真球度,係藉掃描型電子顯微鏡拍攝固體粒 子之電子顯微鏡照片,隨機選出粒子彼此未重疊之100個粒子。對選出之粒子描畫投影像,其投影圖為真圓者;或對粒子之投影像描畫外接圓,再畫出具有該外接圓之半徑之90%之半徑的同心圓,具有粒子之投影像輪廓全部含於同心圓與外接圓之間的形狀者。以此真球數量作為粒子之真球度。 Further, the powder shape is more preferably spherical from the viewpoint that it is hard to be buried in the α-gel film and exhibits a refreshing touch. The spherical shape is specifically a spherical powder having a true sphericity of 70% or more. The so-called true sphericity is the use of scanning electron microscopy to shoot solid particles. The electron micrograph of the sub-particles randomly selects 100 particles whose particles do not overlap each other. Plot the projected image of the selected particle, and the projected image is a true circle; or draw a circumcircle of the projected image of the particle, and draw a concentric circle having a radius of 90% of the radius of the circumscribed circle, having a projected image of the particle All in the shape between the concentric circle and the circumscribed circle. The number of true balls is used as the true sphericity of the particles.

作為球狀粉體,可列舉二氧化矽、矽酸鈣、矽酸鎂等之無機粉體;結晶纖維素、尼龍粉、聚(甲基)丙烯酸酯(甲酯、乙酯)等之有機粉體;形成矽氧烷鍵結三維延伸之網狀構造,於1個矽原子上鍵結了甲基之具有無機與有機之中間性構造的聚甲基倍半矽氧烷粉末等。 Examples of the spherical powder include inorganic powders such as cerium oxide, calcium citrate, and magnesium ruthenate; and organic powders such as crystalline cellulose, nylon powder, and poly(methyl) acrylate (methyl ester or ethyl ester). a polymethylsilsesquioxane powder having an intermediate structure of inorganic and organic groups in which a methyl group is bonded to a helium atom.

此等球狀粉體中,作為成分(D)之粉體,由可與α-凝膠被膜依更大面積接觸的觀點而言,較佳為多孔質之粉體。若為多孔質之粉體,具有對於摩擦不易由被膜脫落的優點。於此,所謂多孔質之粉體,係指於粉體表面,具有多數細孔的粉體。更佳係細孔容積為0.5mL/g以上的粉體。具體而言,較理想為表面呈親水性、多孔質之二氧化矽。作為此等之市售物,可列舉SUNSPHERE H31、SUNSPHERE H-32、SUNSPHERE H-51、SUNSPHERE H-52、SUNSPHERE H-121、SUNSPHERE H-122、SUNSPHERE L-31、SUNSPHERE L-51、SUNSPHERE L-121、(以上為AGC Si-Tech)等。 Among these spherical powders, the powder of the component (D) is preferably a porous powder from the viewpoint of being able to contact the α-gel film over a larger area. In the case of a porous powder, there is an advantage that friction is less likely to fall off from the film. Here, the porous powder refers to a powder having a large number of pores on the surface of the powder. More preferably, the powder has a pore volume of 0.5 mL/g or more. Specifically, it is preferable that the surface is hydrophilic and porous cerium oxide. Such commercially available products include SUNSPHERE H31, SUNSPHERE H-32, SUNSPHERE H-51, SUNSPHERE H-52, SUNSPHERE H-121, SUNSPHERE H-122, SUNSPHERE L-31, SUNSPHERE L-51, SUNSPHERE L -121, (above is AGC Si-Tech) and the like.

成分(D)之粉體可使用1種或2種以上,含量由塗佈後無黏瘩的觀點而言,於全組成中為0.01質量%以上、較佳為0.15質量%以上、更佳0.3質量%以上。而且,由對摩擦不易脫離的觀點而言,於全組成中為30質量%以下、較佳為15質量%以下、更佳為10質量%以下。又,成分(D)之含量係於全組成中為0.01~30質量%、較佳為 0.15~15質量%、更佳為0.3~10質量%。 The powder of the component (D) may be used alone or in combination of two or more kinds, and the content is 0.01% by mass or more, preferably 0.15% by mass or more, and more preferably 0.3 in terms of the total composition. More than % by mass. Moreover, from the viewpoint of the fact that the friction is not easily removed, it is 30% by mass or less, preferably 15% by mass or less, and more preferably 10% by mass or less in the total composition. Further, the content of the component (D) is 0.01 to 30% by mass in the total composition, preferably 0.15 to 15% by mass, more preferably 0.3 to 10% by mass.

另外,成分(A)、(B)、(C)及(D)中,由清爽感與其持續性的觀點而言,(D)/((A)+(B)+(C))的質量比較佳為0.01以上、更佳為0.1以上、進而更佳為0.12以上。而且,由均勻附著於α-凝膠被膜與其持續性的觀點而言,較佳為10以下、更佳為5以下、進而更佳為4以下。成分(A)、(B)、(C)及(D)中,(D)/((A)+(B)+(C))之質量比較佳為0.01~10、更佳為0.1~5、進而更佳為0.12~4。 Further, in the components (A), (B), (C), and (D), the quality of (D)/((A)+(B)+(C)) is based on the sense of freshness and sustainability. The ratio is preferably 0.01 or more, more preferably 0.1 or more, still more preferably 0.12 or more. Moreover, from the viewpoint of uniform adhesion to the α-gel film and its durability, it is preferably 10 or less, more preferably 5 or less, still more preferably 4 or less. In the components (A), (B), (C) and (D), the quality of (D)/((A)+(B)+(C)) is preferably from 0.01 to 10, more preferably from 0.1 to 5. More preferably, it is 0.12~4.

本發明中,成分(E)之水係使用作為乳化化妝料中之溶劑,成為構成乳化化妝料之上述成分及其他成分的剩餘部。含量係於全組成中,較佳為50質量%以上、更佳為60質量%以上,且較佳為98質量%以下、更佳為95質量%以下。成分(E)係在將本發明之乳化化妝料塗佈乾燥後,具有對由成分(A)~(C)及(E)所構成之皮膜賦予柔軟性的作用,可形成能追隨皮膚的皮膜。再者,亦具有使成分(D)不易從皮膜脫落的效果。 In the present invention, the water of the component (E) is used as a solvent in the emulsified cosmetic, and is a remainder of the above-mentioned components and other components constituting the emulsified cosmetic. The content is preferably 50% by mass or more, more preferably 60% by mass or more, and is preferably 98% by mass or less, and more preferably 95% by mass or less, based on the total composition. The component (E) has a function of imparting flexibility to the film composed of the components (A) to (C) and (E) after the emulsion cosmetic of the present invention is applied and dried, and forms a film capable of following the skin. . Further, it has an effect that the component (D) is less likely to fall off from the film.

本發明之乳化化妝料係可將成分(D)之粉體均勻塗佈於皮膚。此係與習知乳化化妝料相異的性能。例如,在於水中油型乳化物中分散了粉體的系統中,若將該乳化物塗佈於皮膚,則與油滴呈連續相之水附著於皮膚表面,若水乾燥,則油滴形成島狀而殘留於皮膚。粉體係附著於油滴而殘留於皮膚上。如此,由於油滴不均勻地殘留於皮膚,故粉體亦不均勻地殘留於皮膚。另一方面,發現本發明之乳化化妝料係乳化化妝料本身成為具有片層狀構造之液體,塗佈乾燥後,於皮膚表面均勻地殘留同質之成分。因此,粉體可附著於皮膚任意處,可使粉體均勻塗佈。 The emulsified cosmetic of the present invention can uniformly apply the powder of the component (D) to the skin. This is a performance different from conventional emulsified cosmetics. For example, in a system in which a powder is dispersed in an oily emulsion in water, if the emulsion is applied to the skin, water in a continuous phase with the oil droplet adheres to the surface of the skin, and if the water is dried, the oil droplet forms an island shape. Remains in the skin. The powder system adheres to the oil droplets and remains on the skin. As described above, since the oil droplets remain unevenly on the skin, the powder does not uniformly remain on the skin. On the other hand, it was found that the emulsified cosmetic emulsified cosmetic of the present invention itself has a liquid having a lamellar structure, and after coating and drying, a homogeneous component remains uniformly on the surface of the skin. Therefore, the powder can be attached to any part of the skin, and the powder can be uniformly coated.

本發明之乳化化妝料可進一步含有(F)多元醇,在塗佈於 皮膚時,可使於皮膚表面所形成之皮膜的柔軟性提升。 The emulsified cosmetic of the present invention may further contain (F) a polyol, which is applied to When the skin is applied, the softness of the film formed on the surface of the skin can be improved.

作為多元醇,可列舉例如甘油、二甘油、聚乙二醇、1,3-丁二醇、異戊二醇、丙二醇、二丙二醇等。 Examples of the polyhydric alcohol include glycerin, diglycerin, polyethylene glycol, 1,3-butylene glycol, isoprene glycol, propylene glycol, and dipropylene glycol.

成分(F)可使用1種或2種以上,由在皮膚表面所形成之皮膜的柔軟性及使用感的觀點而言,含量係於全組成中較佳為1質量%以上、更佳為3質量%以上,且較佳為30質量%以下、更佳為20質量%以下。又,成分(F)之含量係於全組成中較佳為1~30質量%、更佳為3~20質量%。 The component (F) may be used alone or in combination of two or more. From the viewpoint of the flexibility and the feeling of use of the film formed on the surface of the skin, the content is preferably 1% by mass or more, and more preferably 3, in the total composition. The mass% or more is preferably 30% by mass or less, more preferably 20% by mass or less. Further, the content of the component (F) is preferably from 1 to 30% by mass, more preferably from 3 to 20% by mass, based on the total composition.

本發明之乳化化妝料可進一步含有油性成分。 The emulsified cosmetic of the present invention may further contain an oily component.

作為此種油性成分,若為通常化妝料所使用者則無限制,可列舉例如流動石蠟、角鯊烷、凡士林等之烴油;鯨蠟基二甲基丁基醚、乙二醇二辛基醚、甘油單油基醚等之醚油;辛基十二醇肉豆蒄酸酯、軟脂酸異丙酯、硬脂酸丁酯、己二酸二-2-乙基己酯、新戊二醇二癸酸酯、三辛酸甘油酯、橄欖油等之植物油等的酯油;二甲基聚矽氧烷、環狀二甲基聚矽氧烷、甲基苯基聚矽氧烷、胺基改質聚矽氧、羧基改質聚矽氧、醇改質聚矽氧、烷基改質聚矽氧、聚醚改質聚矽氧、氟改質聚矽氧等之聚矽氧油;全氟烷基乙基磷酸、全氟烷基聚氧乙烯磷酸、全氟聚醚、聚四氟乙烯等之氟系油等。 The oily component is not particularly limited as long as it is a user of a general cosmetic, and examples thereof include hydrocarbon oils such as paraffin wax, squalane, and petrolatum; cetyl dimethyl butyl ether and ethylene glycol dioctyl group; Ether oil of ether, glycerol monooleyl ether, etc.; octyldodecanol myristate, isopropyl palmitate, butyl stearate, di-2-ethylhexyl adipate, neopentyl Ester oils such as diol dicaprate, tricaprylin, vegetable oils such as olive oil; dimethyl polyoxane, cyclic dimethyl polyoxyalkylene, methyl phenyl polyoxyalkylene, amine a polyoxygenated oil having a modified polyfluorene oxygen, a carboxyl modified polyoxynium, an alcohol modified polyoxynium oxide, an alkyl modified polyoxynium oxide, a polyether modified polyfluorene oxide, a fluorine modified polyoxyxene, or the like; A fluorine-based oil such as perfluoroalkylethylphosphoric acid, perfluoroalkylpolyoxyethylenephosphoric acid, perfluoropolyether or polytetrafluoroethylene.

此等油性成分可使用1種或2種以上,含量由保存穩定性之觀點而言,於全組成中較佳為0.5質量%以上、更佳為1質量%以上,且較佳為20質量%以下、更佳為15質量%以下。又,油性成分之含量係於全組成中,較佳為0.5~20質量%、更佳為1~15質量%。 The oily component may be used alone or in combination of two or more. The content is preferably 0.5% by mass or more, more preferably 1% by mass or more, and preferably 20% by mass, based on the total stability of the composition. The following is more preferably 15% by mass or less. Further, the content of the oil component is in the total composition, and is preferably from 0.5 to 20% by mass, more preferably from 1 to 15% by mass.

另外,本發明之乳化化妝料,亦可含有通常化妝料所使用之有效成分或添加劑,例如抗壞血酸、菸鹼醯胺、菸鹼酸等之水溶 性維他命類;黃柏樹皮萃取物、甘草萃取物、蘆薈萃取物、馬尾草萃取物、茶萃取物、黃瓜萃取物、丁香萃取物、胡蘿蔔萃取物、金縷梅萃取液、胎盤萃取物、海藻萃取物、七葉樹萃取物、柚子萃取物、羅漢柏萃取物、蜂王漿萃取物、桉樹萃取物、羅漢柏萃取液等之動、植物萃取液;羧基乙烯基聚合物、海藻酸鈉、角叉菜膠、羧基甲基纖維素、羥基乙基纖維素、古亞膠、三仙膠、羧基甲基殼聚糖、玻尿酸鈉、唑啉改質聚矽氧、甲基丙烯酸N,N-二甲胺基乙酯二乙基硫酸鹽‧N,N-二甲基丙烯醯胺‧聚乙二醇二甲基丙烯酸酯共聚物等之增黏劑等。 Further, the emulsified cosmetic of the present invention may contain an active ingredient or an additive used in usual cosmetics, such as water-soluble vitamins such as ascorbic acid, nicotinamide, nicotinic acid, etc.; cork bark extract, licorice extract, Aloe extract, horsetail extract, tea extract, cucumber extract, clove extract, carrot extract, witch hazel extract, placenta extract, algae extract, horse chestnut extract, grapefruit extract, arhat Actin and plant extracts of cypress extract, royal jelly extract, eucalyptus extract, arborvitae extract, etc.; carboxyvinyl polymer, sodium alginate, carrageenan, carboxymethylcellulose, hydroxyethylcellulose , Guaya gum, Sanxian gum, carboxymethyl chitosan, sodium hyaluronate, Oxazoline modified polyfluorene oxide, N,N-dimethylaminoethyl methacrylate diethyl sulfate ‧N,N-dimethyl decylamine ‧ polyethylene glycol dimethacrylate copolymer, etc. Adhesives, etc.

本發明之乳化化妝料可藉以下方法進行製造。 The emulsified cosmetic of the present invention can be produced by the following method.

(製造方法1) (Manufacturing method 1)

步驟1:將成分(A)之未中和物、成分(B)、成分(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(1)的步驟。 Step 1: A step of mixing the unneutralized component (A), the component (B), the component (C), and other oily components, heating to a melting point or higher of the highest melting point component, and stirring to obtain a mixture (1).

步驟2:將成分(D)、(E)、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(1)大致相同溫度,得到混合物(2)的步驟。 Step 2: a step of mixing the components (D), (E), the component (A) neutralizing agent and other water-soluble components, and heating to substantially the same temperature as the mixture (1) to obtain a mixture (2).

步驟3:將混合物(1)與混合物(2)混合,使其均勻後,冷卻至15~35℃的步驟。 Step 3: A step of mixing the mixture (1) with the mixture (2), homogenizing, and cooling to 15 to 35 °C.

(製造方法2) (Manufacturing method 2)

步驟1:將成分(B)、(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(3)的步驟。 Step 1: A step of mixing the components (B), (C) and other oily components, heating to a melting point or higher of the highest melting point component, and stirring to obtain a mixture (3).

步驟2:將成分(A)之未中和物、成分(D)、(E)、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(3)大致相同溫度,得到混合物(4)的步驟。 Step 2: mixing the unneutralized component (A), the component (D), (E), the component (A) neutralizing agent, and other water-soluble components, and heating to a temperature substantially the same as that of the mixture (3). The step of mixture (4).

步驟3:將混合物(3)與混合物(4)混合,使其均勻後,冷卻至15~35℃的步驟。 Step 3: The mixture (3) is mixed with the mixture (4) to make it uniform, and then cooled to a temperature of 15 to 35 °C.

(製造方法3) (Manufacturing method 3)

步驟1:將成分(A)之未中和物、成分(B)、(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(1)的步驟。 Step 1: A step of mixing the unneutralized component (A), the components (B), (C) and other oily components, heating to a melting point or higher of the highest melting point component, and stirring to obtain a mixture (1).

步驟2:將成分(E)之一部分、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(1)大致相同溫度,得到混合物(5)的步驟。 Step 2: a step of mixing the component (E), the component (A) neutralizing agent and other water-soluble components, and heating to substantially the same temperature as the mixture (1) to obtain a mixture (5).

步驟3:將混合物(1)與混合物(5)混合,使其均勻後,冷卻至15~35℃,將剩餘之成分(E)、成分(D)及其他水溶性成分混合,使其均勻的步驟。 Step 3: Mixing the mixture (1) with the mixture (5), homogenizing, cooling to 15 to 35 ° C, mixing the remaining components (E), component (D) and other water-soluble components to make them uniform. step.

(製造方法4) (Manufacturing method 4)

步驟1:將成分(B)、(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(3)的步驟。 Step 1: A step of mixing the components (B), (C) and other oily components, heating to a melting point or higher of the highest melting point component, and stirring to obtain a mixture (3).

步驟2:將成分(A)之未中和物、成分(E)之一部分、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(3)大致相同溫度,得到混合物(6)的步驟。 Step 2: mixing the unneutralized component of the component (A), a portion of the component (E), the neutralizing agent of the component (A), and other water-soluble components, and heating to a temperature substantially the same as that of the mixture (3) to obtain a mixture ( 6) Steps.

步驟3:將混合物(3)與混合物(6)混合,使其均勻後,冷卻至15~35℃,將剩餘之成分(E)、成分(D)及其他水溶性成分混合,使其均勻的步驟。 Step 3: Mixing the mixture (3) with the mixture (6), homogenizing, cooling to 15 to 35 ° C, mixing the remaining components (E), component (D) and other water-soluble components to make them uniform. step.

此等之中,作為本發明之製造方法,製造方法3、4係在事先作成片層狀之化妝料後,再混合成分(D),藉此提高成分(D)對肌膚的附著性,故較佳。由水分保持性高、皮膜之柔軟性高、粉體之保 持性高的觀點而言,更佳為製造方法3。 Among these, as the production method of the present invention, the production methods 3 and 4 are prepared by mixing the component (D) in advance, thereby improving the adhesion of the component (D) to the skin. Preferably. High moisture retention, high flexibility of the film, and powder protection From the viewpoint of high holding power, it is more preferable to manufacture method 3.

本發明之乳化化妝料的構造為α-凝膠(α型結晶),並抑制結晶(γ型結晶)之析出。α-凝膠可藉由X射線所進行的構造解析而確認。 The structure of the emulsified cosmetic of the present invention is an α-gel (α-form crystal) and suppresses precipitation of crystals (γ-form crystal). The α-gel can be confirmed by structural analysis by X-ray.

另外,本發明之乳化化妝料適合作為化妝水、乳液、乳霜、美容液等之皮膚化妝料。 Further, the emulsified cosmetic of the present invention is suitable as a skin cosmetic for lotions, lotions, creams, cosmetic liquids and the like.

本發明之乳化化妝料係塗佈於皮膚,在皮膚表面形成具有α-凝膠構造之皮膜,可使用於保濕皮膚。 The emulsified cosmetic of the present invention is applied to the skin to form a film having an α-gel structure on the surface of the skin, and can be used for moisturizing the skin.

另外,本發明之乳化化妝料可塗佈延展於肌膚而用於護膚。 Further, the emulsified cosmetic of the present invention can be applied to skin for application to skin.

再者,本發明之乳化化妝料係關於塗佈於皮膚使其乾燥,在皮膚表面形成具有α-凝膠構造的皮膜,保濕皮膚的方法。 Further, the emulsified cosmetic of the present invention is a method of applying a film having an α-gel structure to the skin to be dried, applying a film having an α-gel structure, and moisturizing the skin.

本發明之乳化化妝料係關於用於製造皮膚保濕劑者。 The emulsified cosmetic of the present invention relates to those used for the manufacture of skin moisturizers.

關於上述實施形態,本發明進一步揭示有以下的組成物、使用及製造方法。 In the above embodiment, the present invention further discloses the following compositions, uses, and methods of manufacture.

<1>一種乳化化妝料,其含有下述成分(A)、(B)、(C)、(D)及(E):(A)由神經胺醇鹽及離子性界面活性劑所選擇之1種或2種以上的化合物0.01~10質量%;(B)由二直鏈脂肪酸甘油酯及二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物;(C)由一般式(3)所示之化合物、碳數12~22之醇、碳數12~22之單脂肪酸甘油酯、碳數12~22之單烷基甘油醚及碳數12~22之單脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物;[化12] <1> An emulsified cosmetic comprising the following components (A), (B), (C), (D), and (E): (A) selected from a neuroamine alkoxide and an ionic surfactant (1) one or more compounds selected from two linear fatty acid glycerides and two linear fatty acid sorbitan esters; (C) The compound represented by the general formula (3), the alcohol having 12 to 22 carbon atoms, the monoglyceride having 12 to 22 carbon atoms, the monoalkyl glyceryl ether having 12 to 22 carbon atoms, and the single fatty acid having 12 to 22 carbon atoms One or more compounds selected from sorbitan esters; [Chemical 12]

(式中,R11表示亦可取代有羥基、羰基或胺基的碳數4~30之直鏈、分枝鏈或環狀之飽和或不飽和的烴基或氫原子;Z表示亞甲基、次甲基或氧原子;X11、X12及X13分別獨立表示氫原子、羥基或乙醯氧基;X14表示氫原子、乙醯基或甘油基,或與相鄰接之氧原子一起形成側氧基(但,在Z為次甲基時,X11與X12之任一者為氫原子、另一者不存在;在X14形成側氧基時,X13不存在);R12及R13分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;R14表示亦可取代有羥基、羰基或胺基之於主鏈亦可具有醚鍵、酯鍵或醯胺鍵的碳數5~60之直鏈、分枝鏈或環狀之飽和或不飽和的烴基;R15表示氫原子,或亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~30之直鏈或分枝鏈的飽和或不飽和的烴基(但,在R11為氫原子、Z為氧原子時,R15為總碳數10~30之烴基;在R11為烴基時,R15為總碳數1~8之烴基);虛線部表示亦可為不飽和鍵);(D)平均粒徑0.1~30μm之粉體0.01~30質量%;(E)水;成分(A)、(B)及(C)中,(1)(A)/((B)+(C))之質量比為0.04~1;(2)(B)/((B)+(C))之莫耳分率為0.01~0.45;(3)(B)+(C)構成成分中之1化合物單成分所佔有之最大莫耳分率為0.2~0.8。 (wherein R 11 represents a straight-chain, branched chain or cyclic saturated or unsaturated hydrocarbon group or hydrogen atom which may have a hydroxyl group, a carbonyl group or an amine group of 4 to 30; Z represents a methylene group, a methine or an oxygen atom; X 11 , X 12 and X 13 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 14 represents a hydrogen atom, an ethyl fluorenyl group or a glyceryl group, or together with an adjacent oxygen atom Forming a pendant oxy group (however, when Z is a methine group, either of X 11 and X 12 is a hydrogen atom, the other is absent; when X 14 forms a pendant oxy group, X 13 is absent); 12 and R 13 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; and R 14 represents a hydroxyl group, a carbonyl group or an amine group which may be substituted with a hydroxyl group, an ester bond or an anthracene. a linear, branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 5 to 60; R 15 represents a hydrogen atom, or may have a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethyl group. a saturated or unsaturated hydrocarbon group of a linear or branched chain having a total carbon number of 1 to 30, which is a substituent selected from the oxy group (however, when R 11 is a hydrogen atom and Z is an oxygen atom, R 15 is a total carbon number) 10~30 a hydrocarbon group; when R 11 is a hydrocarbon group, R 15 is a hydrocarbon group having a total carbon number of 1 to 8; a dotted line indicates that it may be an unsaturated bond); (D) a powder having an average particle diameter of 0.1 to 30 μm is 0.01 to 30 mass. %; (E) water; in the components (A), (B) and (C), the mass ratio of (1) (A) / ((B) + (C)) is 0.04 ~ 1; (2) (B / ((B) + (C)) has a molar fraction of 0.01 to 0.45; (3) (B) + (C) The composition of the compound has a maximum molar fraction of 0.2%. 0.8.

<2>如上述<1>記載之乳化化妝料,其中,成分(A)較佳為離子性界面活性劑。 <2> The emulsified cosmetic according to the above <1>, wherein the component (A) is preferably an ionic surfactant.

<3>如上述<1>或<2>記載之乳化化妝料,其中,成分(A)之離子性界面活性劑較佳為由聚氧乙烯碳數12~22之烷基醚磷酸或其鹽、碳數12~22之N-烷醯基甲基牛磺酸或其鹽、N-碳數12~22之醯基麩胺酸或其鹽所選擇之1種或2種以上的化合物;去除了對離子之含量,係於全組成中較佳為0.01質量%以上、更佳為0.05質量%以上、進而更佳為0.1質量%以上,且較佳為10質量%以下、更佳為5質量%以下、進而更佳為3質量%以下;又,較佳為0.01~10質量%、更佳為0.05~5質量%、進而更佳為0.1~3質量%。 The emulsified cosmetic according to the above <1> or <2>, wherein the ionic surfactant of the component (A) is preferably an alkyl ether phosphate having a polyoxyethylene carbon number of 12 to 22 or a salt thereof. And one or more compounds selected from the group consisting of N-alkylmercaptomethyl taurine or a salt thereof having a carbon number of 12 to 22 and a thiol glutamic acid having a N-carbon number of 12 to 22 or a salt thereof; The content of the ion is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.1% by mass or more, and further preferably 10% by mass or less, more preferably 5% by mass in the total composition. % or less, more preferably 3% by mass or less, further preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, still more preferably 0.1 to 3% by mass.

<4>如上述<1>~<3>中任一項記載之乳化化妝料,其中,成分(A)較佳為醯基麩胺酸鹽。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (A) is preferably a thiol glutamate.

<5>如上述<1>記載之乳化化妝料,其中,成分(A)較佳為由神經胺醇鹽所選擇之1種或2種以上之化合物,其含量係於全組成中,較佳為0.01質量%以上、更佳為0.05質量%以上、進而更佳為0.1質量%以上,且較佳為10質量%以下、更佳為5質量%以下、進而更佳為3質量%以下;又,較佳為0.01~10質量%、更佳為0.05~5質量%、進而更佳為0.1~3質量%。 <5> The emulsified cosmetic according to the above <1>, wherein the component (A) is preferably one or more compounds selected from the group consisting of a neuroamine alkoxide, and the content thereof is in the total composition, preferably. 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.1% by mass or more, and more preferably 10% by mass or less, more preferably 5% by mass or less, still more preferably 3% by mass or less; It is preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, still more preferably 0.1 to 3% by mass.

<6>如上述<1>~<5>中任一項記載之乳化化妝料,其中,成分(B)較佳為由二直鏈脂肪酸甘油酯所選擇之1種或2種以上的化合物,其含量係於全組成中,較佳為0.01質量%以上、更佳為0.05質量%以上、進而 更佳為0.1質量%以上,且較佳為10質量%以下、更佳為8質量%以下、進而更佳為5質量%以下;又,較佳係0.01~10質量%、更佳係0.05~8質量%、進而更佳係0.1~5質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (B) is preferably one or more compounds selected from the group consisting of di-linear fatty acid glycerides. The content is in the total composition, preferably 0.01% by mass or more, more preferably 0.05% by mass or more, and further More preferably, it is 0.1% by mass or more, and preferably 10% by mass or less, more preferably 8% by mass or less, still more preferably 5% by mass or less; further preferably 0.01% by mass to 10% by mass, more preferably 0.05% by weight 8 mass%, and more preferably 0.1 to 5 mass%.

<7>如上述<6>記載之乳化化妝料,其中,成分(B)之二直鏈脂肪酸甘油酯較佳為二硬脂酸甘油酯。 <7> The emulsified cosmetic according to the above <6>, wherein the two linear fatty acid glycerides of the component (B) are preferably glyceryl distearate.

<8>如上述<1>~<5>中任一項記載之乳化化妝料,其中,成分(B)較佳係由二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物,其含量係於全組成中,較佳為0.01質量%以上、更佳為0.05質量%以上、進而更佳為0.1質量%以上,且較佳為10質量%以下、更佳為8質量%以下、進而更佳為5質量%以下;又,較佳係0.01~10質量%、更佳係0.05~8質量%、進而更佳係0.1~5質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (B) is preferably one or more selected from the group consisting of two linear fatty acid sorbitan esters. The content of the compound is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.1% by mass or more, and further preferably 10% by mass or less, more preferably 8% by mass. % or less, more preferably 5% by mass or less, further preferably 0.01 to 10% by mass, more preferably 0.05 to 8% by mass, still more preferably 0.1 to 5% by mass.

<9>如上述<8>記載之乳化化妝料,其中,成分(B)之二直鏈脂肪酸去水山梨醇酯較佳為二硬脂酸去水山梨醇酯。 <9> The emulsified cosmetic according to the above <8>, wherein the linear fatty acid sorbitan ester of the component (B) is preferably sorbitan distearate.

<10>如上述<1>~<9>中任一項記載之乳化化妝料,其中,成分(C)較佳係由碳數12~22之醇所選擇之1種或2種以上的化合物,其含量係於全組成中,較佳為0.05~15質量%、更佳為0.1~13質量%、進而更佳為0.5~10質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (C) is preferably one or more compounds selected from the group consisting of alcohols having 12 to 22 carbon atoms. The content is in the total composition, preferably 0.05 to 15% by mass, more preferably 0.1 to 13% by mass, still more preferably 0.5 to 10% by mass.

<11>如上述<10>記載之乳化化妝料,其中,成分(C)之碳數12~22之醇較佳為鯨蠟醇或硬脂醇。 <11> The emulsified cosmetic according to the above <10>, wherein the alcohol having 12 to 22 carbon atoms of the component (C) is preferably cetyl alcohol or stearyl alcohol.

<12>如上述<1>~<9>中任一項記載之乳化化妝料,其中,成分(C)較佳係由碳數12~22之單脂肪酸甘油酯所選擇之1種或2種以上的化合物, 其含量係於全組成中,較佳為0.05~15質量%、更佳為0.1~13質量%、進而更佳為0.5~10質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (C) is preferably one or two selected from the group consisting of mono- and fatty acid glycerides having 12 to 22 carbon atoms. The above compounds, The content thereof is in the total composition, and is preferably 0.05 to 15% by mass, more preferably 0.1 to 13% by mass, still more preferably 0.5 to 10% by mass.

<13>如上述<12>記載之乳化化妝料,其中,成分(C)之碳數12~22之單脂肪酸甘油酯較佳為單甘油單硬脂酸酯及單甘油單蘿酸酯所選擇之1種或2種以上。 <13> The emulsified cosmetic according to the above <12>, wherein the mono-fatty acid glyceride having a carbon number of 12 to 22 of the component (C) is preferably selected from the group consisting of monoglyceryl monostearate and monoglycerol monocrole. One or two or more.

<14>如上述<1>~<9>中任一項記載之乳化化妝料,其中,成分(C)較佳係由單碳數16~22之烷基甘油醚所選擇之1種或2種以上的化合物,其含量係於全組成中,較佳為0.05~15質量%、更佳為0.1~13質量%、進而更佳為0.5~10質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (C) is preferably one or two selected from the group consisting of alkyl glyceryl ethers having a single carbon number of 16 to 22. The content of the above compound is preferably from 0.05 to 15% by mass, more preferably from 0.1 to 13% by mass, even more preferably from 0.5 to 10% by mass, based on the total composition.

<15>如上述<14>記載之乳化化妝料,其中,成分(C)之單碳數16~22之烷基甘油醚較佳為單硬脂基甘油醚。 <15> The emulsified cosmetic according to the above <14>, wherein the alkyl glyceryl ether having a single carbon number of 16 to 22 in the component (C) is preferably monostearyl glyceryl ether.

<16>如上述<1>~<9>中任一項記載之乳化化妝料,其中,成分(C)較佳係由碳數12~22之脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物,其含量係於全組成中,較佳為0.05質量%以上、更佳為0.1質量%以上、進而更佳為0.5質量%以上,且較佳為15質量%以下、更佳為13質量%以下、進而更佳為10質量%以下;又,較佳係0.05~15質量%、更佳係0.1~13質量%、進而更佳係0.5~10質量%。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (C) is preferably one selected from the group consisting of fatty acid sorbitan esters having 12 to 22 carbon atoms or The content of the two or more kinds of compounds is preferably 0.05% by mass or more, more preferably 0.1% by mass or more, still more preferably 0.5% by mass or more, and still more preferably 15% by mass or less, and more preferably more. It is 13% by mass or less, more preferably 10% by mass or less, and more preferably 0.05 to 15% by mass, more preferably 0.1 to 13% by mass, still more preferably 0.5 to 10% by mass.

<17>如上述<16>記載之乳化化妝料,其中,成分(C)之碳數12~22之脂肪酸去水山梨醇酯較佳為去水山梨醇單硬脂酸酯。 <17> The emulsified cosmetic according to the above <16>, wherein the fatty acid sorbitan ester having a carbon number of 12 to 22 of the component (C) is preferably sorbitan monostearate.

<18>如上述<1>~<17>中任一項記載之乳化化妝料,其中,(A)/((B)+(C))之質量比較佳為0.06以上、更佳為0.09以上,且較佳為0.5以下、更 佳為0.3以下;又,(A)/((B)+(C))之質量比較佳為0.06~0.5、更佳為0.09~0.3。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the mass of (A)/((B)+(C)) is preferably 0.06 or more, more preferably 0.09 or more. And preferably 0.5 or less, more Preferably, the ratio is 0.3 or less; and the mass of (A)/((B)+(C)) is preferably 0.06 to 0.5, more preferably 0.09 to 0.3.

<19>如上述<1>~<18>中任一項記載之乳化化妝料,其中,(B)/((B)+(C))之莫耳分率較佳為0.03以上、更佳為0.04以上,且較佳為0.4以下、更佳為0.35以下;又,(B)/((B)+(C))之莫耳分率較佳為0.03~0.4、更佳為0.04~0.35。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the (B)/((B)+(C)) has a molar fraction of preferably 0.03 or more, more preferably It is 0.04 or more, and preferably 0.4 or less, more preferably 0.35 or less; further, the molar fraction of (B)/((B)+(C)) is preferably 0.03 to 0.4, more preferably 0.04 to 0.35. .

<20>如上述<1>~<19>中任一項記載之乳化化妝料,其中,(B)+(C)構成成分中之1化合物所佔有之最大莫耳分率較佳為0.3以上,且較佳為0.78以下;又,(B)+(C)構成成分中之1化合物所佔有之最大莫耳分率較佳為0.3~0.78。 The emulsified cosmetic according to any one of the above-mentioned items (1) to (19), wherein the maximum molar fraction of the compound of the (B) + (C) component is preferably 0.3 or more. Further, it is preferably 0.78 or less; and the maximum molar fraction of the compound of the (B) + (C) component is preferably from 0.3 to 0.78.

<21>如上述<1>~<20>中任一項記載之乳化化妝料,其中,構成成分(B)及成分(C)之化合物較佳為3種以上。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (B) and the component (C) are preferably three or more.

<22>如上述<1>~<21>中任一項記載之乳化化妝料,其中,成分(A)、(B)、(C)及(D)中,(D)/((A)+(B)+(C))的質量比較佳為0.01~10、更佳為0.1~5、進而更佳為0.12~4。 The emulsified cosmetic according to any one of the above-mentioned items (1) to (21), wherein, in the components (A), (B), (C) and (D), (D)/((A) The quality of +(B)+(C)) is preferably from 0.01 to 10, more preferably from 0.1 to 5, and even more preferably from 0.12 to 4.

<23>如上述<1>~<22>中任一項記載之乳化化妝料,其中,成分(D)係未經疏水化處理的粉體。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (D) is a powder which is not hydrophobized.

<24>如上述<1>~<23>中任一項記載之乳化化妝料,其中,成分(D)為球狀粉體。 The emulsified cosmetic according to any one of the above-mentioned items, wherein the component (D) is a spherical powder.

<25>如上述<1>~<24>中任一項記載之乳化化妝料,其中,成分(D)為多孔質二氧化矽。 The emulsified cosmetic according to any one of the above aspects, wherein the component (D) is porous ceria.

<26>一種用於護膚的使用,係將上述<1>~<25>中任一項記載之乳化化 妝料塗佈延展至肌膚。 <26> A method for use in skin care, which is an emulsification described in any one of the above <1> to <25> The cosmetic coating spreads to the skin.

<27>一種用於皮膚保濕的使用,係將上述<1>~<25>中任一項記載之乳化化妝料塗佈至皮膚。 <27> The use of the emulsified cosmetic according to any one of the above <1> to <25> to the skin.

<28>一種上述<1>~<25>中任一項記載之乳化化妝料之製造皮膚保濕劑的使用。 <28> Use of a skin moisturizer for producing an emulsified cosmetic according to any one of the above <1> to <25>.

<29>一種皮膚保濕的方法,係將上述<1>~<25>中任一項記載之乳化化妝料塗佈至皮膚使其乾燥。 <29> A method of moisturizing the skin, which comprises applying the emulsified cosmetic according to any one of the above <1> to <25> to the skin and drying it.

<30>一種乳化化妝料之製造方法,係依下述步驟製造上述<1>~<25>中任一項記載之乳化化妝料。 <30> A method of producing an emulsified cosmetic according to any one of the items <1> to <25>.

步驟1:將成分(A)之未中和物、成分(B)、成分(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(1)的步驟。 Step 1: A step of mixing the unneutralized component (A), the component (B), the component (C), and other oily components, heating to a melting point or higher of the highest melting point component, and stirring to obtain a mixture (1).

步驟2:將成分(E)之一部分、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(1)大致相同溫度,得到混合物(5)的步驟。 Step 2: a step of mixing the component (E), the component (A) neutralizing agent and other water-soluble components, and heating to substantially the same temperature as the mixture (1) to obtain a mixture (5).

步驟3:將混合物(1)與混合物(5)混合,使其均勻後,冷卻至15~35℃,將剩餘之成分(E)、成分(D)及其他水溶性成分混合,使其均勻的步驟。 Step 3: Mixing the mixture (1) with the mixture (5), homogenizing, cooling to 15 to 35 ° C, mixing the remaining components (E), component (D) and other water-soluble components to make them uniform. step.

[實施例] [Examples] 製造例1((甲基丙烯酸月桂酯/甲基丙烯酸Na)交聯聚合物的製造) Production Example 1 (Production of (Lauryl Methacrylate/Na) Copolymer)

於燒杯中裝入甲基丙烯酸月桂酯82g、甲基丙烯酸3g、乙二醇二甲基丙烯酸酯15g、過氧化月桂醯基2g,混合攪拌使其溶解。於其中,添加溶解了N-硬脂醯基-N-甲基牛磺酸鈉(SMT)0.75g之離子交換水 400g,以均質機使其分散至粒徑成為2.2μm。將此分散液注入至四頸燒瓶,於攪拌下進行氮置換30分鐘。藉油浴將燒瓶內部溫度加熱至80℃,達到80℃後進行聚合5小時後,滴下1N之NaOH3.9g進行中和。將經聚合之粒子的分散液凍結乾燥,回收粒子藉此得到樹脂粉體。 82 g of lauryl methacrylate, 3 g of methacrylic acid, 15 g of ethylene glycol dimethacrylate, and 2 g of lauryl peroxide were placed in a beaker, and the mixture was stirred and dissolved. Among them, ion-exchanged water in which 0.75 g of N-stearyl sulfonyl-N-methyl taurate (SMT) was dissolved was added. 400 g was dispersed in a homogenizer to a particle size of 2.2 μm. This dispersion was poured into a four-necked flask, and nitrogen substitution was carried out for 30 minutes with stirring. The internal temperature of the flask was heated to 80 ° C by an oil bath, and after polymerization was carried out for 5 hours at 80 ° C, 3.9 g of 1 N NaOH was added dropwise for neutralization. The dispersion of the polymerized particles is freeze-dried, and the particles are recovered to obtain a resin powder.

[實施例1~25、比較例1~8] [Examples 1 to 25, Comparative Examples 1 to 8]

製造表1~4所示組成的乳化化妝料,利用X射線對乾燥皮膜的構造解析、粉體之均勻附著性、粉體對摩擦之脫落難度、無黏瘩感與清爽感之持續及保濕感之持續進行評價。結果合併示於表1~4。 The emulsified cosmetic composition shown in Tables 1 to 4 is used to analyze the structure of the dried film by X-ray, the uniform adhesion of the powder, the difficulty of the powder to rub off, the feeling of no stickiness and refreshing feeling, and the moisturizing feeling. Continue to evaluate. The results are combined and shown in Tables 1-4.

(製造方法) (Production method) (1)實施例1~5、7、9~21、比較例1~8 (1) Examples 1 to 5, 7, 9 to 21, and Comparative Examples 1 to 8

將成分(A)、(B)及(C)加熱至85℃,使其溶解,攪拌均勻。接著,將除了5質量%成分(E)以外之成分(E)及成分(A)之中和劑(精胺酸或麩胺酸)混合,加熱至80~90℃。將此混合物與成分(A)、(B)及(C)之混合物混合攪拌,使其均勻。其後,冷卻至25℃,進一步混合5質量%之成分(E)與成分(D)的混合物,使其均勻,得到乳化化妝料。 The components (A), (B) and (C) were heated to 85 ° C, dissolved, and stirred uniformly. Next, the component (E) other than the component (E) of the component (E) and the neutralizer (arginine or glutamic acid) of the component (A) are mixed and heated to 80 to 90 °C. This mixture was mixed with a mixture of the components (A), (B) and (C) to make it uniform. Thereafter, the mixture was cooled to 25° C., and a mixture of the component (E) and the component (D) in an amount of 5% by mass was further mixed and homogenized to obtain an emulsified cosmetic.

(2)實施例6、8 (2) Examples 6, 8

將成分(B)及(C)加熱至85℃,使其溶解,攪拌均勻。接著,將除了5質量%成分(E)以外之成分(E)及成分(A)之中和物混合,加熱至80~90℃。將此混合物與成分(B)及(C)之混合物混合攪拌,使其均勻。其後,冷卻至25℃,進一步混合5質量%之成分(E)與成分(D)的混合物,使其均勻,得到乳化化妝料。 The components (B) and (C) were heated to 85 ° C, dissolved, and stirred uniformly. Next, the component (E) other than the component (E) of the component (E) and the component (A) are mixed and heated to 80 to 90 °C. This mixture and a mixture of the components (B) and (C) were mixed and stirred to make them uniform. Thereafter, the mixture was cooled to 25° C., and a mixture of the component (E) and the component (D) in an amount of 5% by mass was further mixed and homogenized to obtain an emulsified cosmetic.

(3)實施例22~25 (3) Examples 22 to 25

將成分(A)、(B)及(C)加熱至85℃,使其溶解,攪拌均勻。接著,將成分(E)及成分(A)之中和劑(精胺酸)混合,加熱至80~90℃。將此混合物與成分(A)、(B)及(C)之混合物混合攪拌,使其均勻。其後,冷卻至25℃,進一步混合乙醇與成分(D)及其他之水溶性成分的混合物,使其均勻,得到乳化化妝料。 The components (A), (B) and (C) were heated to 85 ° C, dissolved, and stirred uniformly. Next, the component (E) and the component (A) neutralizer (arginine) are mixed and heated to 80 to 90 °C. This mixture was mixed with a mixture of the components (A), (B) and (C) to make it uniform. Thereafter, the mixture was cooled to 25 ° C, and a mixture of ethanol and the component (D) and other water-soluble components was further mixed and homogenized to obtain an emulsified cosmetic.

(1)利用X射線所進行之乾燥皮膜的構造解析: (1) Structural analysis of the dried film by X-ray:

於黑色人工皮革(seranuback黑,岡本化成品公司製)之表面,使用施用器(YOSHIMITSU公司製),將各化妝料依0.1mm之厚度塗佈,以室溫乾燥1日。分取乾燥皮膜,以X射線構造繞射確認構造。結果如以下所示。 On the surface of black artificial leather (seranuback black, manufactured by Okamoto Chemical Co., Ltd.), each cosmetic was applied to a thickness of 0.1 mm using an applicator (manufactured by YOSHIMITSU Co., Ltd.), and dried at room temperature for one day. The dried film was taken and the structure was confirmed by diffraction with an X-ray structure. The results are shown below.

α型:形成被膜,構造為α型。 α type: a film is formed and configured as an α type.

含有非α型:形成被膜,構造含有非α型。 Contains a non-α type: forms a film, and the structure contains a non-α type.

-:未形成被膜。 -: No film was formed.

(2)粉體之均勻附著性 (2) Uniform adhesion of powder

於黑色人工皮革(seranuback黑,5cm×15cm,岡本化成品公司製)之表面,使用施用器(YOSHIMITSU公司製),將各化妝料依0.1mm之厚度塗佈。由專業官能檢查員5名,以目視依以下基準評價外觀的均勻性,求得平均值。 On the surface of a black artificial leather (seranuback black, 5 cm × 15 cm, manufactured by Okamoto Chemical Co., Ltd.), each cosmetic was applied to a thickness of 0.1 mm using an applicator (manufactured by YOSHIMITSU Co., Ltd.). Five of the professional inspectors were used to evaluate the uniformity of appearance according to the following criteria, and the average value was obtained.

5:粉體非常均勻附著。 5: The powder adheres very evenly.

4:粉體均勻附著。 4: The powder is evenly attached.

3:粉體幾乎均勻附著。 3: The powder adheres almost uniformly.

2:粉體不太均勻。 2: The powder is not uniform.

1:粉體不均勻。 1: The powder is not uniform.

(3)粉體對摩擦之脫落難度: (3) The difficulty of the powder on the friction:

於黑色人工皮革(seranuback黑,5cm×15cm,岡本化成品公司製)之表面,使用施用器(YOSHIMITSU公司製),將各化妝料依0.1mm之厚度塗佈,乾燥1日。其後,使用表面性測定機(HEIDON,SOHGOH KEISO公司製),於50g/cm2之加壓下,以5cm之行程(5cm/s)來回5次。由專業官能檢查員以目視觀察外觀之變化程度,依以下基準評價粉體之脫落難度。 Each of the cosmetic materials was applied to a surface of a black artificial leather (seranuback black, 5 cm × 15 cm, manufactured by Okamoto Chemical Co., Ltd.), and coated with a thickness of 0.1 mm, and dried for one day. Then, using a surface measuring machine (HEIDON, manufactured by SOHGOH KEISO Co., Ltd.), 5 times was carried out with a stroke of 5 cm (5 cm/s) under a pressure of 50 g/cm 2 . The degree of change in appearance was visually observed by a professional inspector, and the difficulty of falling off the powder was evaluated according to the following criteria.

5:粉體幾乎殘留,無外觀變化。 5: The powder remained almost no change in appearance.

4:粉體雖幾乎殘留,但外觀稍有變化。 4: Although the powder remains almost, the appearance slightly changes.

3:粉體稍微減少,外觀有變化。 3: The powder is slightly reduced and the appearance changes.

2:粉體減少,外觀有變化。 2: The powder is reduced and the appearance changes.

1:粉體明顯減少,外觀大幅變化。 1: The powder is significantly reduced and the appearance changes greatly.

(4)無黏瘩感與清爽感之持續: (4) The persistence of no sticky feeling and refreshing feeling:

由5名專業官能檢查員,將各化妝料0.5g使用於全臉。5小時後以手觸摸臉,依以下基準評價無黏瘩感與清爽感,求得平均值。 0.5 g of each cosmetic was applied to the entire face by five professional inspectors. After 5 hours, the face was touched with a hand, and the feeling of no stickiness and refreshment were evaluated according to the following criteria, and the average value was obtained.

5:非常感覺到無黏瘩感與清爽感。 5: I feel very sticky and refreshing.

4:感覺到無黏瘩感與清爽感。 4: Feel the feeling of no sticky and refreshing.

3:稍感覺到無黏瘩感與清爽感。 3: Slightly feel no sticky feeling and refreshing feeling.

2:幾乎未感覺到無黏瘩感與清爽感。 2: Almost no feeling of stickiness and refreshment.

1:未感覺到無黏瘩感與清爽感。 1: No feeling of stickiness and refreshing feeling.

(5)保濕感之持續: (5) Continuation of moisturizing feeling:

由5名專業官能檢查員,將各化妝料0.5g使用於全臉。依以下基準評價5小時後之保濕感,求得平均值。 0.5 g of each cosmetic was applied to the entire face by five professional inspectors. The moisturizing feeling after 5 hours was evaluated according to the following criteria, and the average value was obtained.

5:非常感覺到保濕感。 5: I feel a sense of moisturizing.

4:感覺到保濕感。 4: I feel a moisturizing feeling.

3:稍感覺到保濕感。 3: I feel a little moisturizing.

2:幾乎未感覺到保濕感。 2: Almost no feeling of moisturizing.

1:未感覺到保濕感。 1: No feeling of moisturizing.

[實施例26~27(化妝水)] [Examples 26 to 27 (lotions)]

與實施例22同樣地,製造表5所示組成的化妝水,利用X射線對乾燥皮膜的構造解析、粉體之均勻附著性、粉體對摩擦之脫落難度、無黏瘩感與清爽感之持續及保濕感之持續進行評價。結果合併示於表5。 In the same manner as in Example 22, the lotion having the composition shown in Table 5 was produced, and the structure of the dried film was analyzed by X-ray, the uniform adhesion of the powder, the difficulty of peeling off the powder against friction, and the feeling of no stickiness and refreshment. Continuous and moisturizing continuation is evaluated. The results are combined and shown in Table 5.

[實施例28(乳液)] [Example 28 (emulsion)]

與實施例22同樣地,製造表6所示組成的乳液,利用X射線對乾燥皮膜的構造解析、粉體之均勻附著性、粉體對摩擦之脫落難度、無 黏瘩感與清爽感之持續及保濕感之持續進行評價。結果合併示於表6。 In the same manner as in Example 22, an emulsion having the composition shown in Table 6 was produced, and the structure of the dried film was analyzed by X-rays, the uniform adhesion of the powder, the difficulty of peeling off the powder against friction, and the absence of The viscous sensation and the continuation of the refreshing sensation and the hydration sensation are continuously evaluated. The results are combined and shown in Table 6.

[實施例29~31(乳霜)] [Examples 29 to 31 (cream)]

與實施例22同樣地,製造表7所示組成的乳霜,利用X射線對乾燥皮膜的構造解析、粉體之均勻附著性、粉體對摩擦之脫落難度、無 黏瘩感與清爽感之持續及保濕感之持續進行評價。結果合併示於表7。 In the same manner as in Example 22, the cream having the composition shown in Table 7 was produced, and the structure of the dried film was analyzed by X-rays, the uniform adhesion of the powder, the difficulty of peeling off the powder against friction, and the absence of The viscous sensation and the continuation of the refreshing sensation and the hydration sensation are continuously evaluated. The results are combined and shown in Table 7.

Claims (9)

一種乳化化妝料,其含有下述成分(A)、(B)、(C)、(D)及(E):(A)由神經胺醇鹽及離子性界面活性劑所選擇之1種或2種以上的化合物0.01~10質量%;(B)由二直鏈脂肪酸甘油酯及二直鏈脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物;(C)由一般式(3)所示之化合物、碳數12~22之醇、碳數12~22之單脂肪酸甘油酯、碳數12~22之單烷基甘油醚及碳數12~22之單脂肪酸去水山梨醇酯所選擇之1種或2種以上的化合物; (式中,R11表示亦可取代有羥基、羰基或胺基的碳數4~30之直鏈、分枝鏈或環狀之飽和或不飽和的烴基或氫原子;Z表示亞甲基、次甲基或氧原子;X11、X12及X13分別獨立表示氫原子、羥基或乙醯氧基;X14表示氫原子、乙醯基或甘油基,或與相鄰接之氧原子一起形成側氧基(但,在Z為次甲基時,X11與X12之任一者為氫原子、另一者不存在;在X14形成側氧基時,X13不存在);R12及R13分別獨立表示氫原子、羥基、羥基甲基或乙醯氧基甲基;R14表示亦可取代有羥基、羰基或胺基之於主鏈亦可具有醚鍵、酯鍵或醯胺鍵的碳數5~60之直鏈、分枝鏈或環狀之飽和或不飽和的烴基;R15表示氫原子,或亦可具有由羥基、羥基烷氧基、烷氧基及乙醯氧基所選擇之取代基的總碳數1~30之直鏈或分枝鏈的飽和或不飽和的烴基 (但,在R11為氫原子、Z為氧原子時,R15為總碳數10~30之烴基;在R11為烴基時,R15為總碳數1~8之烴基);虛線部表示亦可為不飽和鍵);(D)平均粒徑0.1~30μm之粉體0.01~30質量%;(E)水;成分(A)、(B)及(C)中,(1)(A)/((B)+(C))之質量比為0.04~1;(2)(B)/((B)+(C))之莫耳分率為0.01~0.45;(3)(B)+(C)構成成分中之1化合物單成分所佔有之最大莫耳分率為0.2~0.8。 An emulsified cosmetic containing the following components (A), (B), (C), (D), and (E): (A) one selected from a neuroamine alkoxide and an ionic surfactant (B) one or more compounds selected from two linear fatty acid glycerides and two linear fatty acid sorbitan esters; (C) from the general formula ( 3) the compound shown, an alcohol having 12 to 22 carbon atoms, a monoglyceride having 12 to 22 carbon atoms, a monoalkyl glyceryl ether having 12 to 22 carbon atoms, and a mono fatty acid sorbitan having a carbon number of 12 to 22 One or more compounds selected from esters; (wherein R 11 represents a straight-chain, branched chain or cyclic saturated or unsaturated hydrocarbon group or hydrogen atom which may have a hydroxyl group, a carbonyl group or an amine group of 4 to 30; Z represents a methylene group, a methine or an oxygen atom; X 11 , X 12 and X 13 each independently represent a hydrogen atom, a hydroxyl group or an ethoxy group; X 14 represents a hydrogen atom, an ethyl fluorenyl group or a glyceryl group, or together with an adjacent oxygen atom Forming a pendant oxy group (however, when Z is a methine group, either of X 11 and X 12 is a hydrogen atom, the other is absent; when X 14 forms a pendant oxy group, X 13 is absent); 12 and R 13 each independently represent a hydrogen atom, a hydroxyl group, a hydroxymethyl group or an ethoxymethyl group; and R 14 represents a hydroxyl group, a carbonyl group or an amine group which may be substituted with a hydroxyl group, an ester bond or an anthracene. a linear, branched or cyclic saturated or unsaturated hydrocarbon group having a carbon number of 5 to 60; R 15 represents a hydrogen atom, or may have a hydroxyl group, a hydroxyalkoxy group, an alkoxy group and an ethyl group. a saturated or unsaturated hydrocarbon group of a linear or branched chain having a total carbon number of 1 to 30, which is a substituent selected from the oxy group (however, when R 11 is a hydrogen atom and Z is an oxygen atom, R 15 is a total carbon number) 10~30 a hydrocarbon group; when R 11 is a hydrocarbon group, R 15 is a hydrocarbon group having a total carbon number of 1 to 8; a dotted line indicates that it may be an unsaturated bond); (D) a powder having an average particle diameter of 0.1 to 30 μm is 0.01 to 30 mass. %; (E) water; in the components (A), (B) and (C), the mass ratio of (1) (A) / ((B) + (C)) is 0.04 ~ 1; (2) (B / ((B) + (C)) has a molar fraction of 0.01 to 0.45; (3) (B) + (C) The composition of the compound has a maximum molar fraction of 0.2%. 0.8. 如申請專利範圍第1項之乳化化妝料,其中,成分(A)、(B)、(C)及(D)中,(D)/((A)+(B)+(C))的質量比為0.01~10。 For example, in the emulsified cosmetic material of claim 1, wherein among the components (A), (B), (C) and (D), (D)/((A)+(B)+(C)) The mass ratio is 0.01~10. 如申請專利範圍第1項之乳化化妝料,其中,構成成分(B)及成分(C)之化合物為3種以上。 The emulsified cosmetic of the first aspect of the invention, wherein the compound of the component (B) and the component (C) is three or more. 如申請專利範圍第1項之乳化化妝料,其中,成分(A)為醯基麩胺酸鹽。 An emulsified cosmetic according to claim 1, wherein the component (A) is a mercapto glutamate. 如申請專利範圍第1項之乳化化妝料,其中,成分(D)係未經疏水化處理的粉體。 An emulsified cosmetic according to the first aspect of the invention, wherein the component (D) is a powder which is not hydrophobized. 如申請專利範圍第1項之乳化化妝料,其中,成分(D)為球狀粉體。 An emulsified cosmetic according to claim 1, wherein the component (D) is a spherical powder. 如申請專利範圍第1項之乳化化妝料,其中,成分(D)為多孔質二氧化矽。 The emulsified cosmetic according to claim 1, wherein the component (D) is porous cerium oxide. 一種將申請專利範圍第1項之乳化化妝料塗佈至皮膚而用於皮膚保濕的使用。 An application for applying the emulsified cosmetic of the first application of the patent scope to the skin for moisturizing the skin. 一種乳化化妝料之製造方法,係用於製造申請專利範圍第1項之乳 化化妝料,具備以下步驟:步驟1:將成分(A)之未中和物、成分(B)、成分(C)及其他油性成分混合,加熱至融點最高成分之融點以上,攪拌而得到混合物(1)的步驟;步驟2:將成分(E)之一部分、成分(A)之中和劑及其他水溶性成分混合,加熱至與混合物(1)大致相同溫度,得到混合物(5)的步驟;步驟3:將混合物(1)與混合物(5)混合,使其均勻後,冷卻至15~35℃,將剩餘之成分(E)、成分(D)及其他水溶性成分混合,使其均勻的步驟。 A method for producing an emulsified cosmetic material, which is used for manufacturing the milk of claim 1 The cosmetic has the following steps: Step 1: Mixing the unneutralized component (A), the component (B), the component (C), and other oily components, heating to a melting point of the highest melting point component, and stirring. a step of obtaining the mixture (1); Step 2: mixing a portion of the component (E), the neutralizing agent (A), and other water-soluble components, and heating to substantially the same temperature as the mixture (1) to obtain a mixture (5) Step 3: Mixing the mixture (1) with the mixture (5), homogenizing, cooling to 15 to 35 ° C, mixing the remaining components (E), component (D) and other water-soluble components, so that Its uniform steps.
TW102144187A 2012-12-03 2013-12-03 Emulsion cosmetic composition TW201427703A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012264801A JP2014108953A (en) 2012-12-03 2012-12-03 Emulsified cosmetic

Publications (1)

Publication Number Publication Date
TW201427703A true TW201427703A (en) 2014-07-16

Family

ID=50883373

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102144187A TW201427703A (en) 2012-12-03 2013-12-03 Emulsion cosmetic composition

Country Status (4)

Country Link
JP (1) JP2014108953A (en)
CN (1) CN104812363B (en)
TW (1) TW201427703A (en)
WO (1) WO2014087955A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103445975B (en) 2012-05-30 2017-08-22 花王株式会社 Emulsification cosmetic composition
WO2017081725A1 (en) * 2015-11-09 2017-05-18 花王株式会社 Oral cavity composition
JP6096396B1 (en) * 2015-11-09 2017-03-15 花王株式会社 Oral composition
JP2018076266A (en) * 2016-11-11 2018-05-17 大東化成工業株式会社 Aqueous dispersion composition and cosmetics containing the same
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
WO2020010036A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
FR3093644B1 (en) * 2019-03-12 2021-07-02 Basf Beauty Care Solutions France Sas New cosmetic use of porous metal oxide spheres
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006036763A (en) * 2004-06-25 2006-02-09 Kao Corp Water-in-oil emulsion composition
JP2006056851A (en) * 2004-08-23 2006-03-02 Shu Uemura:Kk Cosmetic
JP5631530B2 (en) * 2007-12-07 2014-11-26 日揮触媒化成株式会社 Porous silica-based particles having surface smoothness, a method for producing the same, and a cosmetic comprising the porous silica-based particles
CN102724953A (en) * 2009-07-06 2012-10-10 花王株式会社 Emulsified composition

Also Published As

Publication number Publication date
JP2014108953A (en) 2014-06-12
WO2014087955A1 (en) 2014-06-12
CN104812363B (en) 2019-03-05
CN104812363A (en) 2015-07-29

Similar Documents

Publication Publication Date Title
TW201427703A (en) Emulsion cosmetic composition
CN101919791B (en) Personal care composition having reduced eye irritation
US9827175B2 (en) Oil-in-water emulsified skin cosmetic composition
TWI564026B (en) Emulsified cosmetic composition
TWI546082B (en) Skin Cosmetics
RU2642255C2 (en) Improved moistening mixture
CA2691303A1 (en) Personal care sunscreen compositions having reduced eye irritation
WO2018221534A1 (en) Oily humectant and topical skin composition containing same
CN105848634A (en) Oil-in-water emulsion cosmetic for skin
TW200934514A (en) Topical composition
JP5623773B2 (en) Oil-in-water emulsion composition
JP2013189429A (en) Water-in-oil-in-water type emulsified cosmetic
JP6752057B2 (en) Stable composition for skin quality improver
JP2008050315A (en) Eyelash cosmetic
JP6076716B2 (en) Emulsified cosmetics
JP2008120715A (en) Cosmetic composition
WO2020230691A1 (en) Composition containing ceramide and isobutyl oleate
JP2014152146A (en) Oily cosmetic preparation
JP5973493B2 (en) Skin cosmetics
JP6936076B2 (en) Oil-in-water emulsified composition
TW200303761A (en) Liquid cosmetics
JP5064659B2 (en) Pearl agent composition and cosmetics containing the same
JP2005053865A (en) Oil-in-water type emulsified cosmetic
KR102516130B1 (en) Method for producing high density ultrafine particle composition and cosmetic composition comprising high density ultrafine particle composition produced thereby
TW201210625A (en) External preparation for skin